[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_b2e54b30-7ce0-48c0-afeb-58c50207dac9":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:b2e54b30-7ce0-48c0-afeb-58c50207dac9,\"}":180},{"code":4,"data":5,"meta":24},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":26,"manageAffiliations":59,"indexDatabases":122,"url":165,"thumbnailPath":24,"statistic":166,"gsStatistic":24,"type":24,"analyzePriority":24},"b2e54b30-7ce0-48c0-afeb-58c50207dac9","2023-05-29T11:31:02.726+00:00","2025-11-21T10:01:47.401+00:00",[],"Anti-Cancer-Drugs",{"country":12,"issn":14,"introduce":16,"eissn":18,"title":20},{"VOID":13},"US",{"VOID":15},"09594973",{"EN":17},"Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.",{"VOID":19},"14735741",{"EN":21},"Anti-Cancer Drugs","PUBLISHER","PENDING",null,0,[27,35,43,51],{"id":28,"createTime":29,"updateTime":30,"relativeEntities":31,"label":32,"description":34,"parentId":24,"standard":24,"scholarHubFieldId":24},"d9687dc3-fd83-46ff-aef4-1925044c24eb","2023-05-29T10:24:05.052+00:00","2023-11-21T05:08:37.643+00:00",[],{"EN":33},"Oncology",{},{"id":36,"createTime":37,"updateTime":38,"relativeEntities":39,"label":40,"description":42,"parentId":24,"standard":24,"scholarHubFieldId":24},"8d3ee16d-8f93-4e34-b94e-cd3a00dde338","2023-05-29T10:24:36.755+00:00","2023-11-21T05:10:53.773+00:00",[],{"EN":41},"Pharmacology (medical)",{},{"id":44,"createTime":45,"updateTime":46,"relativeEntities":47,"label":48,"description":50,"parentId":24,"standard":24,"scholarHubFieldId":24},"740fbbd4-0204-4499-bc5d-be3ba61fc9be","2023-05-29T10:24:05.032+00:00","2023-11-21T05:08:37.653+00:00",[],{"EN":49},"Cancer Research",{},{"id":52,"createTime":53,"updateTime":54,"relativeEntities":55,"label":56,"description":58,"parentId":24,"standard":24,"scholarHubFieldId":24},"8b51d244-613f-4ff9-b308-d32de7c33ed9","2023-05-29T10:24:08.511+00:00","2023-11-21T07:37:03.796+00:00",[],{"EN":57},"Pharmacology",{},[60,112],{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":70,"url":24,"parentIds":71,"statistic":72},"09833cb8-5a51-4978-b89f-63f09610a98d","2023-05-29T12:06:07.808+00:00","2025-06-11T22:27:16.929+00:00",[],"LIPPINCOTT-WILLIAMS-WILKINS",{"title":67},{"EN":68},"LIPPINCOTT WILLIAMS & WILKINS","AFFILIATION",7,[],{"impactFactor":25,"impactFactorByYear":73,"i10Index":76,"i10IndexLast5Year":25,"totalPublication":76,"totalPublicationByYear":77,"totalCitation":83,"totalCitationByYear":84,"totalCitationPerPublication":101,"totalCitationPerPublicationByYear":102,"hindexLast5Year":111,"hindex":111},{"2012":74,"2013":75},42.33,42,35,{"1978":78,"1980":79,"1985":78,"1986":78,"1999":78,"2000":78,"2001":78,"2002":80,"2004":79,"2005":81,"2006":78,"2007":82,"2008":79,"2009":82,"2010":80,"2011":78},1,3,2,4,5,53806,{"1978":85,"1980":86,"1985":87,"1986":88,"1999":89,"2000":90,"2001":91,"2002":92,"2004":93,"2005":94,"2006":95,"2007":96,"2008":97,"2009":98,"2010":99,"2011":100},61,237,2578,4097,3480,451,3720,1291,3152,12264,1357,2715,1509,14579,1587,728,1537.31,{"1978":85,"1980":103,"1985":87,"1986":88,"1999":89,"2000":90,"2001":91,"2002":104,"2004":105,"2005":106,"2006":95,"2007":107,"2008":108,"2009":109,"2010":110,"2011":100},79,645.5,1050.67,3066,543,503,2915.8,793.5,34,{"id":113,"createTime":114,"updateTime":115,"relativeEntities":116,"slug":117,"properties":118,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":82,"url":24,"parentIds":121,"statistic":24},"34432dfd-8a81-4cb8-a3f5-0ee8b74bbd54","2023-05-29T10:24:05.014+00:00","2025-11-21T10:07:46.877+00:00",[],"Lippincott-Williams-and-Wilkins-Ltd-",{"title":119},{"EN":120},"Lippincott Williams and Wilkins Ltd.",[],[123,145],{"id":124,"indexDatabase":125,"url":137,"indexYears":138,"academicFieldIds":139,"indexDatabaseRanking":144},"b884d7e1-bcf4-4d31-857f-5cf8a2867eea",{"id":126,"createTime":127,"updateTime":128,"relativeEntities":129,"label":130,"description":132,"key":134,"publicationTags":135,"standard":24},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":131,"VI":131},"Scopus - Elsevier",{"EN":131,"VI":133},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[136],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F28727","1990-2025",[140,141,142,143],"46eddd1f-e049-4237-8609-9d60083086ad","ee505398-b96f-423d-82ed-9f73f07d49d4","462e3fe4-4fc0-4c02-80d6-8d2af4fc74ea","e39d1b91-b03d-48ed-87bb-ab5b714ad558","SCOPUS__Q1",{"id":146,"indexDatabase":147,"url":161,"indexYears":24,"academicFieldIds":162,"indexDatabaseRanking":24},"3eff7d21-c513-4602-a8a5-32ae384b4848",{"id":148,"createTime":149,"updateTime":150,"relativeEntities":151,"label":152,"description":154,"key":157,"publicationTags":158,"standard":24},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":153,"VI":153},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":155,"EN":156},"Cơ sở dữ liệu SCIE","SCIE database","scie",[159,160],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=0959-4973",[163,164],"2b943d65-24a8-4546-9232-a1e32c12cb6c","248e54de-c562-4c06-8a10-d7f8a37c06fe","https:\u002F\u002Fjournals.lww.com\u002Fanti-cancerdrugs\u002Fpages\u002Faboutthejournal.aspx",{"impactFactor":25,"impactFactorByYear":167,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":169,"totalCitation":170,"totalCitationByYear":171,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":179,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},6,{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},302,{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},55,56,31,91,47,22,50.33,{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"meta":181,"data":183},{"total":182},"28",[184,442,964,1341,1487,1853,1934,2170,2254,2529],{"id":185,"createTime":186,"updateTime":186,"relativeEntities":187,"slug":188,"properties":189,"entityType":202,"verifyStatus":23,"verifyTime":186,"verifyNote":203,"syncStatus":23,"languages":204,"translateLanguages":24,"viewCount":25,"primaryUrl":206,"fullTextUrl":24,"authors":207,"publicationType":278,"publisherRelationship":279,"citationCount":317,"citationInfo":318,"publishDate":321,"publishYear":322,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":323,"isForceReanalyzing":441},"9a983d1a-4972-4364-aaf1-669a518d1d4d","2024-12-27T23:38:57.530+00:00",[],"Downregulation-of-GST%CF%80-expression-by-tryptanthrin-contributing-to-sensitization-of-doxorubicin-resistant-MCF-7-cells-through-c-jun-NH2-terminal-kinase-mediated-apoptosis",{"mag":190,"keywords":192,"openalex":193,"abstract":195,"title":196,"pm":198,"doi":200},{"VOID":191},"2003298766",{},{"VOID":194},"W2003298766",{},{"EN":197},"Downregulation of GSTπ expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis",{"VOID":199},"19318911",{"VOID":201},"10.1097\u002Fcad.0b013e32832a2cd4","PUBLICATION","Author affiliation is blank",[205],"EN","https:\u002F\u002Fjournals.lww.com\u002F00001813-200906000-00009",[208,217,239,258,267],{"id":209,"sortIndex":79,"researcher":24,"roles":210,"affiliations":211,"properties":212},"f1baa036-42fc-4d2c-909a-617b49161ced",[],[],{"openalex":213,"title":215},{"VOID":214},"A5105523682",{"EN":216},"Shih-Yun Tseng",{"id":218,"sortIndex":81,"researcher":24,"roles":219,"affiliations":220,"properties":232},"5d272a3c-9cd7-4780-90f5-a36e49db0d5b",[],[221],{"id":222,"sortIndex":25,"affiliation":223,"properties":24},"e015b410-679f-4d19-b362-8c9f775b7378",{"id":224,"createTime":225,"updateTime":226,"relativeEntities":227,"slug":228,"properties":229,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"0a42a599-6858-4ec7-9702-3dce25e690f5","2024-12-27T23:38:57.567+00:00","2025-06-11T23:10:34.878+00:00",[],"to-Yen-Hui-Chen-PhD-Graduate-Institute-of-Pharmaceutical-Sciences-College-of-Medicine-National-Taiwan-University-No-1-Section-1-Jen-Ai-Road-Taipei-10051-Taiwan",{"title":230},{"EN":231},"to Yen-Hui Chen, PhD, Graduate Institute of Pharmaceutical Sciences, College of Medicine, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei 10051, Taiwan",{"openalex":233,"orcid":235,"title":237},{"VOID":234},"A5015242729",{"VOID":236},"https:\u002F\u002Forcid.org\u002F0000-0003-0267-225X",{"EN":238},"Yen‐Hui Chen",{"id":240,"sortIndex":25,"researcher":24,"roles":241,"affiliations":242,"properties":253},"d56adc42-4c98-4ba0-8260-c9593f89c060",[],[243],{"id":244,"sortIndex":25,"affiliation":245,"properties":24},"d7dfc0c2-4e09-4455-b814-b389d6068436",{"id":246,"createTime":247,"updateTime":247,"relativeEntities":248,"slug":249,"properties":250,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"48acd4e4-4870-4c1e-8ad7-6a40396b96f0","2024-12-27T23:38:57.540+00:00",[],"Graduate-Institute-of-Pharmaceutical-Sciences-College-of-Medicine-National-Taiwan-University-Taipei-Taiwan-",{"title":251},{"EN":252},"Graduate Institute of Pharmaceutical Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan.",{"openalex":254,"title":256},{"VOID":255},"A5063756318",{"EN":257},"Sung-Tsai Yu",{"id":259,"sortIndex":78,"researcher":24,"roles":260,"affiliations":261,"properties":262},"0fe97f07-cb01-4dc1-94f3-d4ed72b412f6",[],[],{"openalex":263,"title":265},{"VOID":264},"A5051101817",{"EN":266},"Tzer-Ming Chen",{"id":268,"sortIndex":80,"researcher":24,"roles":269,"affiliations":270,"properties":271},"f1bb1b5e-9fdd-48d5-a7af-9bbd30ecc377",[],[],{"openalex":272,"orcid":274,"title":276},{"VOID":273},"A5002032472",{"VOID":275},"https:\u002F\u002Forcid.org\u002F0000-0002-4310-8834",{"EN":277},"Ji‐Wang Chern","ARTICLE",{"url":24,"publisher":280,"properties":310},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":281,"slug":10,"properties":282,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":288,"manageAffiliations":289,"indexDatabases":290,"url":165,"thumbnailPath":24,"statistic":305,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":283,"issn":284,"introduce":285,"eissn":286,"title":287},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[291,298],{"id":124,"indexDatabase":292,"url":137,"indexYears":138,"academicFieldIds":297,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":293,"label":294,"description":295,"key":134,"publicationTags":296,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":299,"url":161,"indexYears":24,"academicFieldIds":304,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":300,"label":301,"description":302,"key":157,"publicationTags":303,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":306,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":307,"totalCitation":170,"totalCitationByYear":308,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":309,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":311,"pages":313,"issue":315},{"VOID":312},"20",{"VOID":314},"382-388",{"VOID":316},"5",59,{"total":317,"publishYear":24,"statisticByYear":319},{"2012":81,"2013":320,"2014":80,"2015":168,"2016":80,"2017":82,"2018":79,"2019":79,"2020":168,"2021":79,"2022":81,"2023":78,"2024":81},8,"2009-06-01",2009,[324,328,332,336,340,344,348,352,356,360,364,368,372,376,380,384,388,391,395,399,403,407,411,415,418,421,425,429,433,437],{"id":24,"text":325,"url":24,"identifiers":326},"Krishna, 2000, Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs, Eur J Pharm Sci, 11, 265, 10.1016\u002FS0928-0987(00)00114-7",{"doi":327},"10.1016\u002FS0928-0987(00)00114-7",{"id":24,"text":329,"url":24,"identifiers":330},"Gottesman, 2006, The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research, FEBS Letters, 580, 998, 10.1016\u002Fj.febslet.2005.12.060",{"doi":331},"10.1016\u002Fj.febslet.2005.12.060",{"id":24,"text":333,"url":24,"identifiers":334},"Luqmani, 2005, Mechanisms of drug resistance in cancer chemotherapy, Med Princ Pract, 14, 35, 10.1159\u002F000086183",{"doi":335},"10.1159\u002F000086183",{"id":24,"text":337,"url":24,"identifiers":338},"Kuzmich, 1991, Detoxification mechanisms and tumor cell resistance to anticancer drugs, Med Res Rev, 11, 185, 10.1002\u002Fj.1098-1128.1991.tb00003.x",{"doi":339},"10.1002\u002Fj.1098-1128.1991.tb00003.x",{"id":24,"text":341,"url":24,"identifiers":342},"Batist, 1986, Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells, J Biol Chem, 261, 15544, 10.1016\u002FS0021-9258(18)66748-1",{"doi":343},"10.1016\u002FS0021-9258(18)66748-1",{"id":24,"text":345,"url":24,"identifiers":346},"Lai, 1991, Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines, Int J Cancer, 49, 688, 10.1002\u002Fijc.2910490511",{"doi":347},"10.1002\u002Fijc.2910490511",{"id":24,"text":349,"url":24,"identifiers":350},"Adler, 1999, Regulation of JNK signaling by GSTp, EMBO J, 18, 1321, 10.1093\u002Femboj\u002F18.5.1321",{"doi":351},"10.1093\u002Femboj\u002F18.5.1321",{"id":24,"text":353,"url":24,"identifiers":354},"Wang, 2001, Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus, J Biol Chem, 276, 20999, 10.1074\u002Fjbc.M101355200",{"doi":355},"10.1074\u002Fjbc.M101355200",{"id":24,"text":357,"url":24,"identifiers":358},"Asakura, 2004, Chemotherapeutic agents that induce mitochondrial apoptosis, Curr Cancer Drug Targets, 4, 577, 10.2174\u002F1568009043332772",{"doi":359},"10.2174\u002F1568009043332772",{"id":24,"text":361,"url":24,"identifiers":362},"Asakura, 2007, Conformational change in the active center region of GST P1-1, due to binding of a synthetic conjugate of DXR with GSH, enhanced JNK-mediated apoptosis, Apoptosis, 12, 1269, 10.1007\u002Fs10495-007-0053-0",{"doi":363},"10.1007\u002Fs10495-007-0053-0",{"id":24,"text":365,"url":24,"identifiers":366},"Ploemen, 1990, Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate, Biochem Pharmacol, 40, 1631, 10.1016\u002F0006-2952(90)90465-W",{"doi":367},"10.1016\u002F0006-2952(90)90465-W",{"id":24,"text":369,"url":24,"identifiers":370},"Flatgaard, 1993, Isozyme specificity of novel glutathione-S-transferase inhibitors, Cancer Chemother Pharmacol, 33, 63, 10.1007\u002FBF00686025",{"doi":371},"10.1007\u002FBF00686025",{"id":24,"text":373,"url":24,"identifiers":374},"Drake, 1987, Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme, J Biol Chem, 262, 16739, 10.1016\u002FS0021-9258(18)49317-9",{"doi":375},"10.1016\u002FS0021-9258(18)49317-9",{"id":24,"text":377,"url":24,"identifiers":378},"Kamath, 1992, Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone, Biochem Pharmacol, 44, 937, 10.1016\u002F0006-2952(92)90126-4",{"doi":379},"10.1016\u002F0006-2952(92)90126-4",{"id":24,"text":381,"url":24,"identifiers":382},"Danz, 2001, Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria, Planta Med, 67, 411, 10.1055\u002Fs-2001-15805",{"doi":383},"10.1055\u002Fs-2001-15805",{"id":24,"text":385,"url":24,"identifiers":386},"Kataoka, 2001, Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils, J Gastroenterol, 36, 5, 10.1007\u002Fs005350170147",{"doi":387},"10.1007\u002Fs005350170147",{"id":24,"text":389,"url":24,"identifiers":390},"Koya-Miyata, 2001, Prevention of azoxymethane-induced intestinal tumors by a crude ethyl acetate-extract and tryptanthrin extracted from Polygonum tinctorium Lour, Anticancer Res, 21, 3295",{},{"id":24,"text":392,"url":24,"identifiers":393},"Yu, 2007, Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells, Biochem Biophys Res Commun, 358, 79, 10.1016\u002Fj.bbrc.2007.04.107",{"doi":394},"10.1016\u002Fj.bbrc.2007.04.107",{"id":24,"text":396,"url":24,"identifiers":397},"Beck, 1994, High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias, Cancer Lett, 86, 135, 10.1016\u002F0304-3835(94)90190-2",{"doi":398},"10.1016\u002F0304-3835(94)90190-2",{"id":24,"text":400,"url":24,"identifiers":401},"Lacave, 1998, Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas, Br J Cancer, 77, 694, 10.1038\u002Fbjc.1998.115",{"doi":402},"10.1038\u002Fbjc.1998.115",{"id":24,"text":404,"url":24,"identifiers":405},"Habig, 1974, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J Biol Chem, 249, 7130, 10.1016\u002FS0021-9258(19)42083-8",{"doi":406},"10.1016\u002FS0021-9258(19)42083-8",{"id":24,"text":408,"url":24,"identifiers":409},"Townsend, 2003, The role of glutathione-S-transferase in anti-cancer drug resistance, Oncogene, 22, 7369, 10.1038\u002Fsj.onc.1206940",{"doi":410},"10.1038\u002Fsj.onc.1206940",{"id":24,"text":412,"url":24,"identifiers":413},"Fojo, 2003, Strategies for reversing drug resistance, Oncogene, 22, 7512, 10.1038\u002Fsj.onc.1206951",{"doi":414},"10.1038\u002Fsj.onc.1206951",{"id":24,"text":416,"url":24,"identifiers":417},"Tew, 1988, Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines, Cancer Res, 48, 3622",{},{"id":24,"text":419,"url":24,"identifiers":420},"Clapper, 1990, Sensitization of human colon tumor xenografts to L-phenylalanine mustard using ethacrynic acid, J Cell Pharmacol, 1, 71",{},{"id":24,"text":422,"url":24,"identifiers":423},"Asakura, 2001, Suppression of GST-P by treatment with glutathione-doxorubicin conjugate induces potent apoptosis in rat hepatoma cells, Int J Cancer, 94, 171, 10.1002\u002Fijc.1465",{"doi":424},"10.1002\u002Fijc.1465",{"id":24,"text":426,"url":24,"identifiers":427},"Narang, 2007, Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of doxorubicin, Chemotherapy, 53, 210, 10.1159\u002F000100812",{"doi":428},"10.1159\u002F000100812",{"id":24,"text":430,"url":24,"identifiers":431},"Takada, 2008, c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells, Cancer Chemother Pharmacol, 62, 569, 10.1007\u002Fs00280-007-0638-x",{"doi":432},"10.1007\u002Fs00280-007-0638-x",{"id":24,"text":434,"url":24,"identifiers":435},"Kim, 2003, JNK\u002FSAPK mediates doxorubicin-induced differentiation and apoptosis in MCF-7 breast cancer cells, Breast Cancer Res Treat, 79, 321, 10.1023\u002FA:1024043302583",{"doi":436},"10.1023\u002FA:1024043302583",{"id":24,"text":438,"url":24,"identifiers":439},"Bugg, 1991, Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide, Proc Natl Acad Sci U S A, 88, 7654, 10.1073\u002Fpnas.88.17.7654",{"doi":440},"10.1073\u002Fpnas.88.17.7654",false,{"id":443,"createTime":444,"updateTime":444,"relativeEntities":445,"slug":446,"properties":447,"entityType":202,"verifyStatus":460,"verifyTime":444,"verifyNote":461,"syncStatus":23,"languages":462,"translateLanguages":24,"viewCount":25,"primaryUrl":463,"fullTextUrl":24,"authors":464,"publicationType":278,"publisherRelationship":486,"citationCount":173,"citationInfo":524,"publishDate":526,"publishYear":527,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":528,"isForceReanalyzing":441},"bde748c3-b9c4-45fc-b971-78b5572419c7","2024-09-11T23:27:59.643+00:00",[],"Peripheral-benzodiazepine-receptor-and-its-clinical-targeting",{"mag":448,"keywords":450,"openalex":451,"abstract":453,"title":454,"pm":456,"doi":458},{"VOID":449},"2091324525",{},{"VOID":452},"W2091324525",{},{"EN":455},"Peripheral benzodiazepine receptor and its clinical targeting",{"VOID":457},"15494634",{"VOID":459},"10.1097\u002F00001813-200409000-00001","VERIFIED","Auto Verify",[205],"http:\u002F\u002Fjournals.lww.com\u002F00001813-200409000-00001",[465],{"id":466,"sortIndex":25,"researcher":24,"roles":467,"affiliations":468,"properties":479},"a9593aa4-e4be-400b-8f82-f727396f02a3",[],[469],{"id":470,"sortIndex":25,"affiliation":471,"properties":24},"94c1abec-2acd-4da3-86ae-6f4d158a4dfa",{"id":472,"createTime":473,"updateTime":473,"relativeEntities":474,"slug":475,"properties":476,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"478cbfb8-ef85-4d10-9eed-a042bc54a4d3","2024-09-11T23:27:59.660+00:00",[],"to-D-Decaudin-Service-d-H%C3%A9matologie-Institut-Curie-26-rue-d-Ulm-75-248-Paris-Cedex-05-France",{"title":477},{"EN":478},"to D. Decaudin, Service d'Hématologie, Institut Curie, 26 rue d'Ulm, 75.248 Paris Cedex 05, France",{"openalex":480,"orcid":482,"title":484},{"VOID":481},"A5089229030",{"VOID":483},"https:\u002F\u002Forcid.org\u002F0000-0003-2254-0043",{"EN":485},"Didier Decaudin",{"url":24,"publisher":487,"properties":517},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":488,"slug":10,"properties":489,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":495,"manageAffiliations":496,"indexDatabases":497,"url":165,"thumbnailPath":24,"statistic":512,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":490,"issn":491,"introduce":492,"eissn":493,"title":494},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[498,505],{"id":124,"indexDatabase":499,"url":137,"indexYears":138,"academicFieldIds":504,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":500,"label":501,"description":502,"key":134,"publicationTags":503,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":506,"url":161,"indexYears":24,"academicFieldIds":511,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":507,"label":508,"description":509,"key":157,"publicationTags":510,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":513,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":514,"totalCitation":170,"totalCitationByYear":515,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":516,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":518,"pages":520,"issue":522},{"VOID":519},"15",{"VOID":521},"737-745",{"VOID":523},"8",{"total":173,"publishYear":24,"statisticByYear":525},{"2012":81,"2013":80,"2015":78,"2017":79,"2019":80,"2021":80,"2024":78},"2004-09-01",2004,[529,533,537,541,545,549,552,556,560,564,568,572,576,579,583,587,591,595,599,603,607,611,615,619,623,627,631,635,639,643,647,651,655,659,663,667,671,674,678,682,686,690,694,698,702,706,709,713,717,721,724,727,730,733,737,741,745,749,753,757,761,765,767,771,774,778,782,786,790,794,798,802,806,810,814,818,822,825,829,833,837,841,845,849,853,857,861,865,869,873,877,881,885,889,893,897,901,905,909,913,917,921,925,929,933,937,941,945,948,952,956,960],{"id":24,"text":530,"url":24,"identifiers":531},"Anholt, 1986, J Biol Chem, 261, 576, 10.1016\u002FS0021-9258(17)36131-8",{"doi":532},"10.1016\u002FS0021-9258(17)36131-8",{"id":24,"text":534,"url":24,"identifiers":535},"Braestrup, 1977, Proc Natl Acad Sci USA, 74, 3805, 10.1073\u002Fpnas.74.9.3805",{"doi":536},"10.1073\u002Fpnas.74.9.3805",{"id":24,"text":538,"url":24,"identifiers":539},"Bernassau, 1993, J Mol Graphics, 11, 236, 10.1016\u002F0263-7855(93)80003-A",{"doi":540},"10.1016\u002F0263-7855(93)80003-A",{"id":24,"text":542,"url":24,"identifiers":543},"Olson, 1988, Eur J Pharmacol, 152, 47, 10.1016\u002F0014-2999(88)90834-5",{"doi":544},"10.1016\u002F0014-2999(88)90834-5",{"id":24,"text":546,"url":24,"identifiers":547},"O??Beirne, 1990, Eur J Biochem, 188, 131, 10.1111\u002Fj.1432-1033.1990.tb15380.x",{"doi":548},"10.1111\u002Fj.1432-1033.1990.tb15380.x",{"id":24,"text":550,"url":24,"identifiers":551},"Hardwick, 1999, Cancer Res, 59, 831",{},{"id":24,"text":553,"url":24,"identifiers":554},"Zoratti, 1995, Biochim Biophys Acta, 1241, 139, 10.1016\u002F0304-4157(95)00003-A",{"doi":555},"10.1016\u002F0304-4157(95)00003-A",{"id":24,"text":557,"url":24,"identifiers":558},"Kroemer, 1997, Immunol Today, 18, 44, 10.1016\u002FS0167-5699(97)80014-X",{"doi":559},"10.1016\u002FS0167-5699(97)80014-X",{"id":24,"text":561,"url":24,"identifiers":562},"Galiegue, 1999, J Biol Chem, 270, 2938, 10.1074\u002Fjbc.274.5.2938",{"doi":563},"10.1074\u002Fjbc.274.5.2938",{"id":24,"text":565,"url":24,"identifiers":566},"Blahos, 1995, J Biol Chem, 270, 20285, 10.1074\u002Fjbc.270.35.20285",{"doi":567},"10.1074\u002Fjbc.270.35.20285",{"id":24,"text":569,"url":24,"identifiers":570},"Li, 2001, Proc Natl Acad Sci USA, 98, 1267, 10.1073\u002Fpnas.98.3.1267",{"doi":571},"10.1073\u002Fpnas.98.3.1267",{"id":24,"text":573,"url":24,"identifiers":574},"West, 2001, Endocrinology, 142, 502, 10.1210\u002Fendo.142.1.8052",{"doi":575},"10.1210\u002Fendo.142.1.8052",{"id":24,"text":577,"url":24,"identifiers":578},"Li, 2001, Mol Endocrinol, 15, 2211",{},{"id":24,"text":580,"url":24,"identifiers":581},"Everett, 2000, J Exp Med, 191, 1487, 10.1084\u002Fjem.191.9.1487",{"doi":582},"10.1084\u002Fjem.191.9.1487",{"id":24,"text":584,"url":24,"identifiers":585},"Moynagh, 1993, Biochem Pharmacol, 46, 821, 10.1016\u002F0006-2952(93)90490-N",{"doi":586},"10.1016\u002F0006-2952(93)90490-N",{"id":24,"text":588,"url":24,"identifiers":589},"Itzhak, 1994, Brain Res, 660, 346, 10.1016\u002F0006-8993(94)91311-0",{"doi":590},"10.1016\u002F0006-8993(94)91311-0",{"id":24,"text":592,"url":24,"identifiers":593},"Sridaran, 1999, J Mol Endocrinol, 22, 45, 10.1677\u002Fjme.0.0220045",{"doi":594},"10.1677\u002Fjme.0.0220045",{"id":24,"text":596,"url":24,"identifiers":597},"Rey, 2000, Biochem Pharmacol, 60, 1639, 10.1016\u002FS0006-2952(00)00500-1",{"doi":598},"10.1016\u002FS0006-2952(00)00500-1",{"id":24,"text":600,"url":24,"identifiers":601},"Golani, 2001, Biochemistry, 40, 10213, 10.1021\u002Fbi010431+",{"doi":602},"10.1021\u002Fbi010431+",{"id":24,"text":604,"url":24,"identifiers":605},"Trincavelli, 2002, J Cell Biochem, 84, 636, 10.1002\u002Fjcb.10035",{"doi":606},"10.1002\u002Fjcb.10035",{"id":24,"text":608,"url":24,"identifiers":609},"Rao, 2001, J Neurosci Res, 64, 493, 10.1002\u002Fjnr.1101",{"doi":610},"10.1002\u002Fjnr.1101",{"id":24,"text":612,"url":24,"identifiers":613},"Hauet, 2002, Transplantation, 74, 1507, 10.1097\u002F00007890-200212150-00006",{"doi":614},"10.1097\u002F00007890-200212150-00006",{"id":24,"text":616,"url":24,"identifiers":617},"Mazzone, 2000, J Am Coll Cardiol, 36, 746, 10.1016\u002FS0735-1097(00)00778-6",{"doi":618},"10.1016\u002FS0735-1097(00)00778-6",{"id":24,"text":620,"url":24,"identifiers":621},"Kuhlmann, 1999, Toxicol Sci, 48, 107, 10.1093\u002Ftoxsci\u002F48.1.107",{"doi":622},"10.1093\u002Ftoxsci\u002F48.1.107",{"id":24,"text":624,"url":24,"identifiers":625},"Hazell, 2003, Neurosci Lett, 349, 13, 10.1016\u002FS0304-3940(03)00649-9",{"doi":626},"10.1016\u002FS0304-3940(03)00649-9",{"id":24,"text":628,"url":24,"identifiers":629},"Mankowski, 2003, J Neurovirol, 9, 94, 10.1080\u002F13550280390173283",{"doi":630},"10.1080\u002F13550280390173283",{"id":24,"text":632,"url":24,"identifiers":633},"Haussinger, 2002, J Gastroenterol Hepatol, 17, S256, 10.1046\u002Fj.1440-1746.17.s3.10.x",{"doi":634},"10.1046\u002Fj.1440-1746.17.s3.10.x",{"id":24,"text":636,"url":24,"identifiers":637},"Sauvageau, 2002, Metab Brain Dis, 17, 3, 10.1023\u002FA:1014044128845",{"doi":638},"10.1023\u002FA:1014044128845",{"id":24,"text":640,"url":24,"identifiers":641},"Lacor, 1999, Brain Res, 815, 70, 10.1016\u002FS0006-8993(98)01105-6",{"doi":642},"10.1016\u002FS0006-8993(98)01105-6",{"id":24,"text":644,"url":24,"identifiers":645},"Raghavendra Rao, 2000, Exp Neurol, 161, 102, 10.1006\u002Fexnr.1999.7269",{"doi":646},"10.1006\u002Fexnr.1999.7269",{"id":24,"text":648,"url":24,"identifiers":649},"Lukeman, 1988, Life Sci, 42, 367, 10.1016\u002F0024-3205(88)90074-4",{"doi":650},"10.1016\u002F0024-3205(88)90074-4",{"id":24,"text":652,"url":24,"identifiers":653},"Leschiner, 2000, Neuropsychobiology, 42, 127, 10.1159\u002F000026682",{"doi":654},"10.1159\u002F000026682",{"id":24,"text":656,"url":24,"identifiers":657},"Zavala, 1990, Blood, 76, 184, 10.1182\u002Fblood.V76.1.184.184",{"doi":658},"10.1182\u002Fblood.V76.1.184.184",{"id":24,"text":660,"url":24,"identifiers":661},"Zavala, 1990, Lancet, 336, 758, 10.1016\u002F0140-6736(90)92260-O",{"doi":662},"10.1016\u002F0140-6736(90)92260-O",{"id":24,"text":664,"url":24,"identifiers":665},"Carmel, 1999, Biochem Pharmacol, 58, 273, 10.1016\u002FS0006-2952(99)00093-3",{"doi":666},"10.1016\u002FS0006-2952(99)00093-3",{"id":24,"text":668,"url":24,"identifiers":669},"Beinlich, 2000, Biochem Pharmacol, 60, 397, 10.1016\u002FS0006-2952(00)00325-7",{"doi":670},"10.1016\u002FS0006-2952(00)00325-7",{"id":24,"text":672,"url":24,"identifiers":673},"Papadopoulos, 2000, Anticancer Res, 20, 2835",{},{"id":24,"text":675,"url":24,"identifiers":676},"Sanger, 2000, Eur J Cancer, 36, 2157, 10.1016\u002FS0959-8049(00)00298-7",{"doi":677},"10.1016\u002FS0959-8049(00)00298-7",{"id":24,"text":679,"url":24,"identifiers":680},"Strohmeier, 2002, Biochem Pharmacol, 64, 99, 10.1016\u002FS0006-2952(02)01059-6",{"doi":681},"10.1016\u002FS0006-2952(02)01059-6",{"id":24,"text":683,"url":24,"identifiers":684},"Hardwick, 2002, Cancer Genet Cytogenet, 139, 48, 10.1016\u002FS0165-4608(02)00604-0",{"doi":685},"10.1016\u002FS0165-4608(02)00604-0",{"id":24,"text":687,"url":24,"identifiers":688},"Papadopoulos, 1997, J Biol Chem, 272, 32129, 10.1074\u002Fjbc.272.51.32129",{"doi":689},"10.1074\u002Fjbc.272.51.32129",{"id":24,"text":691,"url":24,"identifiers":692},"Rao, 2002, Endocr Res, 28, 387, 10.1081\u002FERC-120016813",{"doi":693},"10.1081\u002FERC-120016813",{"id":24,"text":695,"url":24,"identifiers":696},"Sutter, 2002, Int J Cancer, 102, 318, 10.1002\u002Fijc.10724",{"doi":697},"10.1002\u002Fijc.10724",{"id":24,"text":699,"url":24,"identifiers":700},"Maaser, 2001, Br J Cancer, 85, 1771, 10.1054\u002Fbjoc.2001.2181",{"doi":701},"10.1054\u002Fbjoc.2001.2181",{"id":24,"text":703,"url":24,"identifiers":704},"Thompson, 2001, Endocrinology, 142, 4076, 10.1210\u002Fendo.142.9.8354",{"doi":705},"10.1210\u002Fendo.142.9.8354",{"id":24,"text":707,"url":24,"identifiers":708},"Decaudin, 2002, Cancer Res, 62, 388",{},{"id":24,"text":710,"url":24,"identifiers":711},"Batra, 1994, Prostate, 24, 269, 10.1002\u002Fpros.2990240509",{"doi":712},"10.1002\u002Fpros.2990240509",{"id":24,"text":714,"url":24,"identifiers":715},"Whittle, 2001, J Clin Neurosci, 8, 430, 10.1054\u002Fjocn.2000.0936",{"doi":716},"10.1054\u002Fjocn.2000.0936",{"id":24,"text":718,"url":24,"identifiers":719},"Venturini, 1998, Life Sci, 63, 1269, 10.1016\u002FS0024-3205(98)00388-9",{"doi":720},"10.1016\u002FS0024-3205(98)00388-9",{"id":24,"text":722,"url":24,"identifiers":723},"Batra, 1998, Int J Oncol, 12, 1295",{},{"id":24,"text":725,"url":24,"identifiers":726},"Miettinen, 1995, Cancer Res, 55, 2691",{},{"id":24,"text":728,"url":24,"identifiers":729},"Batra, 2000, Anticancer Res, 20, 463",{},{"id":24,"text":731,"url":24,"identifiers":732},"Maaser, 2002, Clin Cancer Res, 8, 3205",{},{"id":24,"text":734,"url":24,"identifiers":735},"Garnier, 1994, J Biol Chem, 269, 22105, 10.1016\u002FS0021-9258(17)31762-3",{"doi":736},"10.1016\u002FS0021-9258(17)31762-3",{"id":24,"text":738,"url":24,"identifiers":739},"Tsankova, 1997, Eur J Pharmacol, 294, 601, 10.1016\u002F0014-2999(95)00603-6",{"doi":740},"10.1016\u002F0014-2999(95)00603-6",{"id":24,"text":742,"url":24,"identifiers":743},"Li, 1998, Endocrinology, 139, 4991, 10.1210\u002Fendo.139.12.6390",{"doi":744},"10.1210\u002Fendo.139.12.6390",{"id":24,"text":746,"url":24,"identifiers":747},"Papadopoulos, 1998, Endocr Res, 24, 479, 10.3109\u002F07435809809032636",{"doi":748},"10.3109\u002F07435809809032636",{"id":24,"text":750,"url":24,"identifiers":751},"Culty, 1999, J Steroid Biochem Mol Biol, 69, 123, 10.1016\u002FS0960-0760(99)00056-4",{"doi":752},"10.1016\u002FS0960-0760(99)00056-4",{"id":24,"text":754,"url":24,"identifiers":755},"Lacapere, 2003, Steroids, 68, 569, 10.1016\u002FS0039-128X(03)00101-6",{"doi":756},"10.1016\u002FS0039-128X(03)00101-6",{"id":24,"text":758,"url":24,"identifiers":759},"Delavoie, 2003, Biochemistry, 42, 4506, 10.1021\u002Fbi0267487",{"doi":760},"10.1021\u002Fbi0267487",{"id":24,"text":762,"url":24,"identifiers":763},"Hauet, 2002, Endocr Res, 28, 395, 10.1081\u002FERC-120016814",{"doi":764},"10.1081\u002FERC-120016814",{"id":24,"text":640,"url":24,"identifiers":766},{"doi":642},{"id":24,"text":768,"url":24,"identifiers":769},"Lang, 2002, Curr Med Chem, 9, 1411, 10.2174\u002F0929867023369745",{"doi":770},"10.2174\u002F0929867023369745",{"id":24,"text":772,"url":24,"identifiers":773},"Papadopoulos, 2003, Ann Pharm Fr, 61, 30",{},{"id":24,"text":775,"url":24,"identifiers":776},"Cascio, 2000, J Steroid Biochem Mol Biol, 75, 177, 10.1016\u002FS0960-0760(00)00163-1",{"doi":777},"10.1016\u002FS0960-0760(00)00163-1",{"id":24,"text":779,"url":24,"identifiers":780},"McGeer, 1988, Alzheim Dis AssDisord, 2, 331, 10.1097\u002F00002093-198802040-00001",{"doi":781},"10.1097\u002F00002093-198802040-00001",{"id":24,"text":783,"url":24,"identifiers":784},"Messmer, 1998, Neurosci Lett, 241, 53, 10.1016\u002FS0304-3940(97)00967-1",{"doi":785},"10.1016\u002FS0304-3940(97)00967-1",{"id":24,"text":787,"url":24,"identifiers":788},"Cagnin, 2001, Lancet, 359, 461, 10.1016\u002FS0140-6736(01)05625-2",{"doi":789},"10.1016\u002FS0140-6736(01)05625-2",{"id":24,"text":791,"url":24,"identifiers":792},"Brown, 2003, Neurobiol Aging, 24, 57, 10.1016\u002FS0197-4580(02)00048-9",{"doi":793},"10.1016\u002FS0197-4580(02)00048-9",{"id":24,"text":795,"url":24,"identifiers":796},"Laird, 1989, Eur J Pharmacol, 171, 25, 10.1016\u002F0014-2999(89)90426-3",{"doi":797},"10.1016\u002F0014-2999(89)90426-3",{"id":24,"text":799,"url":24,"identifiers":800},"Garnier, 1993, Endocrinology, 132, 444, 10.1210\u002Fendo.132.1.8380386",{"doi":801},"10.1210\u002Fendo.132.1.8380386",{"id":24,"text":803,"url":24,"identifiers":804},"Camins, 1995, Eur J Pharmacol, 272, 289, 10.1016\u002F0014-2999(94)00652-N",{"doi":805},"10.1016\u002F0014-2999(94)00652-N",{"id":24,"text":807,"url":24,"identifiers":808},"Neary, 1995, Brain Res, 675, 27, 10.1016\u002F0006-8993(95)00031-K",{"doi":809},"10.1016\u002F0006-8993(95)00031-K",{"id":24,"text":811,"url":24,"identifiers":812},"Landau, 1998, Biochem Pharmacol, 56, 1029, 10.1016\u002FS0006-2952(98)00149-X",{"doi":813},"10.1016\u002FS0006-2952(98)00149-X",{"id":24,"text":815,"url":24,"identifiers":816},"Hardwick, 2001, Int J Cancer, 94, 322, 10.1002\u002Fijc.1472",{"doi":817},"10.1002\u002Fijc.1472",{"id":24,"text":819,"url":24,"identifiers":820},"Brown, 2000, Cancer Lett, 156, 125, 10.1016\u002FS0304-3835(00)00451-1",{"doi":821},"10.1016\u002FS0304-3835(00)00451-1",{"id":24,"text":823,"url":24,"identifiers":824},"Coleman, 1997, 363",{},{"id":24,"text":826,"url":24,"identifiers":827},"Torres, 2000, Eur J Pharmacol, 408, 199, 10.1016\u002FS0014-2999(00)00760-3",{"doi":828},"10.1016\u002FS0014-2999(00)00760-3",{"id":24,"text":830,"url":24,"identifiers":831},"Waterfield, 1999, Rheumatology, 38, 1068, 10.1093\u002Frheumatology\u002F38.11.1068",{"doi":832},"10.1093\u002Frheumatology\u002F38.11.1068",{"id":24,"text":834,"url":24,"identifiers":835},"Bribes, 2002, Eur J Pharmacol, 452, 111, 10.1016\u002FS0014-2999(02)02231-8",{"doi":836},"10.1016\u002FS0014-2999(02)02231-8",{"id":24,"text":838,"url":24,"identifiers":839},"Bessler, 1997, Int J Immunopharmacol, 19, 249, 10.1016\u002FS0192-0561(97)00013-1",{"doi":840},"10.1016\u002FS0192-0561(97)00013-1",{"id":24,"text":842,"url":24,"identifiers":843},"Camins, 1995, Immunopharmacology, 29, 159, 10.1016\u002F0162-3109(94)00055-K",{"doi":844},"10.1016\u002F0162-3109(94)00055-K",{"id":24,"text":846,"url":24,"identifiers":847},"Canat, 1993, Biochem Pharmacol, 46, 551, 10.1016\u002F0006-2952(93)90535-5",{"doi":848},"10.1016\u002F0006-2952(93)90535-5",{"id":24,"text":850,"url":24,"identifiers":851},"Marino, 2001, Pharmacology, 63, 42, 10.1159\u002F000056111",{"doi":852},"10.1159\u002F000056111",{"id":24,"text":854,"url":24,"identifiers":855},"Sacerdote, 1993, Life Sci, 53, 653, 10.1016\u002F0024-3205(93)90275-8",{"doi":856},"10.1016\u002F0024-3205(93)90275-8",{"id":24,"text":858,"url":24,"identifiers":859},"Galiegue, 2003, Curr Med Chem, 10, 1563, 10.2174\u002F0929867033457223",{"doi":860},"10.2174\u002F0929867033457223",{"id":24,"text":862,"url":24,"identifiers":863},"Leducq, 2003, J Pharmacol Exp Ther, 306, 828, 10.1124\u002Fjpet.103.052068",{"doi":864},"10.1124\u002Fjpet.103.052068",{"id":24,"text":866,"url":24,"identifiers":867},"Carayon, 1996, Blood, 87, 3170, 10.1182\u002Fblood.V87.8.3170.bloodjournal8783170",{"doi":868},"10.1182\u002Fblood.V87.8.3170.bloodjournal8783170",{"id":24,"text":870,"url":24,"identifiers":871},"Miccoli, 1999, Biochem Pharmacol, 58, 715, 10.1016\u002FS0006-2952(99)00151-3",{"doi":872},"10.1016\u002FS0006-2952(99)00151-3",{"id":24,"text":874,"url":24,"identifiers":875},"Pelaia, 1997, Gen Pharmacol, 28, 495, 10.1016\u002FS0306-3623(96)00270-4",{"doi":876},"10.1016\u002FS0306-3623(96)00270-4",{"id":24,"text":878,"url":24,"identifiers":879},"Nakajima, 1995, Biol Pharm Bull, 18, 903, 10.1248\u002Fbpb.18.903",{"doi":880},"10.1248\u002Fbpb.18.903",{"id":24,"text":882,"url":24,"identifiers":883},"Taketani, 1994, J Biol Chem, 269, 7527, 10.1016\u002FS0021-9258(17)37318-0",{"doi":884},"10.1016\u002FS0021-9258(17)37318-0",{"id":24,"text":886,"url":24,"identifiers":887},"Taketani, 1995, J Biochem (Tokyo), 117, 875, 10.1093\u002Foxfordjournals.jbchem.a124790",{"doi":888},"10.1093\u002Foxfordjournals.jbchem.a124790",{"id":24,"text":890,"url":24,"identifiers":891},"Susin, 1997, J Exp Med, 186, 25, 10.1084\u002Fjem.186.1.25",{"doi":892},"10.1084\u002Fjem.186.1.25",{"id":24,"text":894,"url":24,"identifiers":895},"Kroemer, 2003, Biochem Biophys Res Com, 304, 433, 10.1016\u002FS0006-291X(03)00614-4",{"doi":896},"10.1016\u002FS0006-291X(03)00614-4",{"id":24,"text":898,"url":24,"identifiers":899},"Ravagnan, 2002, J Cell Physiol, 192, 131, 10.1002\u002Fjcp.10111",{"doi":900},"10.1002\u002Fjcp.10111",{"id":24,"text":902,"url":24,"identifiers":903},"Stoebner, 1999, Br J Dermatol, 140, 1010, 10.1046\u002Fj.1365-2133.1999.02896.x",{"doi":904},"10.1046\u002Fj.1365-2133.1999.02896.x",{"id":24,"text":906,"url":24,"identifiers":907},"Casellas, 2002, Neurochem Int, 40, 475, 10.1016\u002FS0197-0186(01)00118-8",{"doi":908},"10.1016\u002FS0197-0186(01)00118-8",{"id":24,"text":910,"url":24,"identifiers":911},"Patterson, 2000, Cell Death Differ, 7, 137, 10.1038\u002Fsj.cdd.4400640",{"doi":912},"10.1038\u002Fsj.cdd.4400640",{"id":24,"text":914,"url":24,"identifiers":915},"Everett, 2002, J Exp Med, 196, 1127, 10.1084\u002Fjem.20011247",{"doi":916},"10.1084\u002Fjem.20011247",{"id":24,"text":918,"url":24,"identifiers":919},"Kupczyk-Subotkowska, 1997, J Med Chem, 40, 1726, 10.1021\u002Fjm960592p",{"doi":920},"10.1021\u002Fjm960592p",{"id":24,"text":922,"url":24,"identifiers":923},"Hirsch, 1998, Exp Cell Res, 241, 426, 10.1006\u002Fexcr.1998.4084",{"doi":924},"10.1006\u002Fexcr.1998.4084",{"id":24,"text":926,"url":24,"identifiers":927},"Miccoli, 1998, J Natl Cancer Inst, 90, 1400, 10.1093\u002Fjnci\u002F90.18.1400",{"doi":928},"10.1093\u002Fjnci\u002F90.18.1400",{"id":24,"text":930,"url":24,"identifiers":931},"Bono, 1999, Biochem Biophys Res Commun, 265, 457, 10.1006\u002Fbbrc.1999.1683",{"doi":932},"10.1006\u002Fbbrc.1999.1683",{"id":24,"text":934,"url":24,"identifiers":935},"Tanimoto, 1999, Jpn J Pharmacol, 79, 177, 10.1254\u002Fjjp.79.177",{"doi":936},"10.1254\u002Fjjp.79.177",{"id":24,"text":938,"url":24,"identifiers":939},"Kessel, 2001, Photochem Photobiol, 74, 346, 10.1562\u002F0031-8655(2001)074\u003C0346:TROTPB>2.0.CO;2",{"doi":940},"10.1562\u002F0031-8655(2001)074\u003C0346:TROTPB>2.0.CO;2",{"id":24,"text":942,"url":24,"identifiers":943},"Banker, 2002, Leuk Res, 26, 91, 10.1016\u002FS0145-2126(01)00112-6",{"doi":944},"10.1016\u002FS0145-2126(01)00112-6",{"id":24,"text":946,"url":24,"identifiers":947},"Jakubikova, 2002, Neoplasma, 49, 231",{},{"id":24,"text":949,"url":24,"identifiers":950},"Morris, 2002, Photochem Photobiol, 75, 652, 10.1562\u002F0031-8655(2002)075\u003C0652:TPBRIP>2.0.CO;2",{"doi":951},"10.1562\u002F0031-8655(2002)075\u003C0652:TPBRIP>2.0.CO;2",{"id":24,"text":953,"url":24,"identifiers":954},"Sutter, 2003, Br J Cancer, 89, 564, 10.1038\u002Fsj.bjc.6601125",{"doi":955},"10.1038\u002Fsj.bjc.6601125",{"id":24,"text":957,"url":24,"identifiers":958},"LeFur, 1983, Life Sci, 33, 449, 10.1016\u002F0024-3205(83)90794-4",{"doi":959},"10.1016\u002F0024-3205(83)90794-4",{"id":24,"text":961,"url":24,"identifiers":962},"Costantini, 2000, J Natl Cancer Inst, 92, 1042, 10.1093\u002Fjnci\u002F92.13.1042",{"doi":963},"10.1093\u002Fjnci\u002F92.13.1042",{"id":965,"createTime":966,"updateTime":966,"relativeEntities":967,"slug":968,"properties":969,"entityType":202,"verifyStatus":460,"verifyTime":982,"verifyNote":461,"syncStatus":23,"languages":983,"translateLanguages":24,"viewCount":25,"primaryUrl":984,"fullTextUrl":24,"authors":985,"publicationType":278,"publisherRelationship":1073,"citationCount":177,"citationInfo":1111,"publishDate":1113,"publishYear":1114,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":1115,"isForceReanalyzing":441},"e67547a4-9fc0-485a-8198-a40b91df8038","2024-09-12T22:19:32.394+00:00",[],"Doxorubicin-induces-apoptosis-in-Jurkat-cells-by-mitochondria-dependent-and-mitochondria-independent-mechanisms-under-normoxic-and-hypoxic-conditions",{"mag":970,"keywords":972,"openalex":973,"abstract":975,"title":976,"pm":978,"doi":980},{"VOID":971},"2332756390",{},{"VOID":974},"W2332756390",{},{"EN":977},"Doxorubicin induces apoptosis in Jurkat cells by mitochondria-dependent and mitochondria-independent mechanisms under normoxic and hypoxic conditions",{"VOID":979},"25734830",{"VOID":981},"10.1097\u002Fcad.0000000000000223","2024-09-12T22:19:32.393+00:00",[205],"https:\u002F\u002Fjournals.lww.com\u002F00001813-201507000-00001",[986,1008,1025],{"id":987,"sortIndex":25,"researcher":24,"roles":988,"affiliations":989,"properties":1001},"7f19540e-ccdb-4290-9498-c199ea54ad50",[],[990],{"id":991,"sortIndex":25,"affiliation":992,"properties":24},"c81c596d-dfdc-4d3d-8670-8b2275960644",{"id":993,"createTime":994,"updateTime":995,"relativeEntities":996,"slug":997,"properties":998,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"d7555a00-2537-404d-a5b4-669665f9f1c6","2024-01-03T14:25:49.305+00:00","2024-09-12T22:19:32.412+00:00",[],"Neuroscience-Research-Group-Medical-Research-Institute-Faculty-of-Medicine-University-of-Antioquia-UdeA-Medellin-Colombia",{"title":999},{"VI":1000},"Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, University of Antioquia (UdeA), Medellin, Colombia",{"openalex":1002,"orcid":1004,"title":1006},{"VOID":1003},"A5024066765",{"VOID":1005},"https:\u002F\u002Forcid.org\u002F0000-0002-8824-379X",{"EN":1007},"Miguel Mendivil‐Perez",{"id":1009,"sortIndex":78,"researcher":24,"roles":1010,"affiliations":1011,"properties":1018},"b6d1c3d0-69fd-4a33-ad5e-758452ec5b2b",[],[1012],{"id":1013,"sortIndex":25,"affiliation":1014,"properties":24},"f5df9bc2-e279-4421-8787-b52e3b685096",{"id":993,"createTime":994,"updateTime":995,"relativeEntities":1015,"slug":997,"properties":1016,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1017},{"VI":1000},{"openalex":1019,"orcid":1021,"title":1023},{"VOID":1020},"A5042019799",{"VOID":1022},"https:\u002F\u002Forcid.org\u002F0000-0002-0557-0411",{"EN":1024},"Carlos Velez‐Pardo",{"id":1026,"sortIndex":80,"researcher":24,"roles":1027,"affiliations":1028,"properties":1066},"b03a620d-12fd-45ea-b346-1a25ed43d6d9",[],[1029,1039,1049,1060],{"id":1030,"sortIndex":80,"affiliation":1031,"properties":24},"bdb92768-58d6-4218-a3f9-c7249641a530",{"id":1032,"createTime":1033,"updateTime":1033,"relativeEntities":1034,"slug":1035,"properties":1036,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"a521f0b9-1133-4dd2-b4f9-a769f8d8aec0","2024-09-12T22:19:32.464+00:00",[],"fax-574-219-6444",{"title":1037},{"EN":1038},"fax: +574 219 6444",{"id":1040,"sortIndex":79,"affiliation":1041,"properties":24},"435a0b5a-74df-4538-aed4-09a5de7508bc",{"id":1042,"createTime":1043,"updateTime":1043,"relativeEntities":1044,"slug":1045,"properties":1046,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"2e31a343-fc15-4017-8806-1982c2934b4f","2024-09-12T22:19:32.471+00:00",[],"to-Marlene-Jimenez-Del-Rio-MSc-DSc-Neuroscience-Research-Group-Medical-Research-Institute-Faculty-of-Medicine-University-of-Antioquia-UdeA-Calle-70-no-52-21-and-Calle-62-52-59-Building-1-Room-412-SIU-Medellin-Colombia-Tel-574-291-6457",{"title":1047},{"EN":1048},"to Marlene Jimenez-Del-Rio, MSc, DSc, Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, University of Antioquia(UdeA), Calle 70 no. 52-21, and Calle 62 # 52-59, Building 1, Room 412, SIU Medellin, Colombia Tel: +574 291 6457",{"id":1050,"sortIndex":78,"affiliation":1051,"properties":24},"2aaaaa63-1d37-45bc-a8d1-b65e5863d99f",{"id":1052,"createTime":1053,"updateTime":1054,"relativeEntities":1055,"slug":1056,"properties":1057,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"f8505247-fc80-475b-97e9-35c35aa72209","2024-07-18T05:30:07.704+00:00","2025-02-11T10:07:02.325+00:00",[],"e-mail-email-protected-",{"title":1058},{"EN":1059},"e-mail: [email protected]",{"id":1061,"sortIndex":25,"affiliation":1062,"properties":24},"f3120305-da27-4493-a130-21c69a4920a6",{"id":993,"createTime":994,"updateTime":995,"relativeEntities":1063,"slug":997,"properties":1064,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1065},{"VI":1000},{"openalex":1067,"orcid":1069,"title":1071},{"VOID":1068},"A5033560020",{"VOID":1070},"https:\u002F\u002Forcid.org\u002F0000-0003-3477-2386",{"EN":1072},"Marlene Jiménez-Del-Río",{"url":24,"publisher":1074,"properties":1104},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1075,"slug":10,"properties":1076,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1082,"manageAffiliations":1083,"indexDatabases":1084,"url":165,"thumbnailPath":24,"statistic":1099,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1077,"issn":1078,"introduce":1079,"eissn":1080,"title":1081},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[1085,1092],{"id":124,"indexDatabase":1086,"url":137,"indexYears":138,"academicFieldIds":1091,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":1087,"label":1088,"description":1089,"key":134,"publicationTags":1090,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":1093,"url":161,"indexYears":24,"academicFieldIds":1098,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":1094,"label":1095,"description":1096,"key":157,"publicationTags":1097,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":1100,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":1101,"totalCitation":170,"totalCitationByYear":1102,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":1103,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":1105,"pages":1107,"issue":1109},{"VOID":1106},"26",{"VOID":1108},"583-598",{"VOID":1110},"6",{"total":177,"publishYear":24,"statisticByYear":1112},{"2015":80,"2016":81,"2017":80,"2018":79,"2019":80,"2020":79,"2021":78,"2022":79,"2023":78,"2024":78},"2015-07-01",2015,[1116,1120,1124,1128,1132,1136,1140,1144,1148,1152,1156,1160,1164,1168,1171,1175,1179,1183,1187,1191,1195,1199,1203,1207,1211,1215,1219,1223,1227,1231,1235,1239,1243,1247,1251,1255,1259,1263,1267,1271,1275,1279,1282,1286,1290,1293,1297,1301,1305,1309,1313,1317,1321,1325,1329,1333,1337],{"id":24,"text":1117,"url":24,"identifiers":1118},"Kantarjian, 2004, . Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia., Cancer, 101, 2788, 10.1002\u002Fcncr.20668",{"doi":1119},"10.1002\u002Fcncr.20668",{"id":24,"text":1121,"url":24,"identifiers":1122},"Lowas, 2009, Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia., Pediatr Blood Cancer, 52, 814, 10.1002\u002Fpbc.21980",{"doi":1123},"10.1002\u002Fpbc.21980",{"id":24,"text":1125,"url":24,"identifiers":1126},"Weng, 2004, . Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia., Science, 306, 269, 10.1126\u002Fscience.1102160",{"doi":1127},"10.1126\u002Fscience.1102160",{"id":24,"text":1129,"url":24,"identifiers":1130},"Rohwer, 2011, Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways., Drug Resist Updat, 14, 191, 10.1016\u002Fj.drup.2011.03.001",{"doi":1131},"10.1016\u002Fj.drup.2011.03.001",{"id":24,"text":1133,"url":24,"identifiers":1134},"Frolova, 2012, . Regulation of HIF-1 signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment., Cancer Biol Ther, 13, 858, 10.4161\u002Fcbt.20838",{"doi":1135},"10.4161\u002Fcbt.20838",{"id":24,"text":1137,"url":24,"identifiers":1138},"Cui, 2013, Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells., Blood Cells Mol Dis, 51, 177, 10.1016\u002Fj.bcmd.2013.05.003",{"doi":1139},"10.1016\u002Fj.bcmd.2013.05.003",{"id":24,"text":1141,"url":24,"identifiers":1142},"Wu, 2011, The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy., Mol Pharm, 8, 1996, 10.1021\u002Fmp200261n",{"doi":1143},"10.1021\u002Fmp200261n",{"id":24,"text":1145,"url":24,"identifiers":1146},"Breier, 2013, New insight into p-glycoprotein as a drug target., Anticancer Agents Med Chem, 13, 159, 10.2174\u002F187152013804487380",{"doi":1147},"10.2174\u002F187152013804487380",{"id":24,"text":1149,"url":24,"identifiers":1150},"Hanahan, 2011, Hallmarks of cancer: the next generation., Cell, 144, 646, 10.1016\u002Fj.cell.2011.02.013",{"doi":1151},"10.1016\u002Fj.cell.2011.02.013",{"id":24,"text":1153,"url":24,"identifiers":1154},"Fuchs, 2011, Programmed cell death in animal development and disease., Cell, 147, 742, 10.1016\u002Fj.cell.2011.10.033",{"doi":1155},"10.1016\u002Fj.cell.2011.10.033",{"id":24,"text":1157,"url":24,"identifiers":1158},"Kroemer, 2009, . Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009., Cell Death Differ, 16, 3, 10.1038\u002Fcdd.2008.150",{"doi":1159},"10.1038\u002Fcdd.2008.150",{"id":24,"text":1161,"url":24,"identifiers":1162},"Galluzzi, 2012, . Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012., Cell Death Differ, 19, 107, 10.1038\u002Fcdd.2011.96",{"doi":1163},"10.1038\u002Fcdd.2011.96",{"id":24,"text":1165,"url":24,"identifiers":1166},"Gewirtz, 1999, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin., Biochem Pharmacol, 57, 727, 10.1016\u002FS0006-2952(98)00307-4",{"doi":1167},"10.1016\u002FS0006-2952(98)00307-4",{"id":24,"text":1169,"url":24,"identifiers":1170},"Denard, 2012, Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1., Elife (Cambridge), 1, e00090",{},{"id":24,"text":1172,"url":24,"identifiers":1173},"Mizutani, 2005, Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide., Life Sci, 76, 1439, 10.1016\u002Fj.lfs.2004.05.040",{"doi":1174},"10.1016\u002Fj.lfs.2004.05.040",{"id":24,"text":1176,"url":24,"identifiers":1177},"Gamen, 2000, . Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells., Exp Cell Res, 258, 223, 10.1006\u002Fexcr.2000.4924",{"doi":1178},"10.1006\u002Fexcr.2000.4924",{"id":24,"text":1180,"url":24,"identifiers":1181},"Brantley-Finley, 2003, . The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide., Biochem Pharmacol, 66, 459, 10.1016\u002FS0006-2952(03)00255-7",{"doi":1182},"10.1016\u002FS0006-2952(03)00255-7",{"id":24,"text":1184,"url":24,"identifiers":1185},"van Delft, 2010, Apoptosis and non-inflammatory phagocytosis can be induced by mitochondrial damage without caspases., Cell Death Differ, 17, 821, 10.1038\u002Fcdd.2009.166",{"doi":1186},"10.1038\u002Fcdd.2009.166",{"id":24,"text":1188,"url":24,"identifiers":1189},"Lopez-Royuela, 2010, . Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells., Biochem Pharmacol, 79, 1746, 10.1016\u002Fj.bcp.2010.02.010",{"doi":1190},"10.1016\u002Fj.bcp.2010.02.010",{"id":24,"text":1192,"url":24,"identifiers":1193},"Tsang, 2003, Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis., Life Sci, 73, 2047, 10.1016\u002FS0024-3205(03)00566-6",{"doi":1194},"10.1016\u002FS0024-3205(03)00566-6",{"id":24,"text":1196,"url":24,"identifiers":1197},"Aguilo, 2012, . Cytotoxicity of quinone drugs on highly proliferative human leukemia T cells: reactive oxygen species generation and inactive shortened SOD1 isoform implications., Chem Biol Interact, 198, 18, 10.1016\u002Fj.cbi.2012.05.001",{"doi":1198},"10.1016\u002Fj.cbi.2012.05.001",{"id":24,"text":1200,"url":24,"identifiers":1201},"Ashikawa, 2004, Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues., Biochem Pharmacol, 67, 353, 10.1016\u002Fj.bcp.2003.08.039",{"doi":1202},"10.1016\u002Fj.bcp.2003.08.039",{"id":24,"text":1204,"url":24,"identifiers":1205},"Campbell, 2004, Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B., Mol Cell, 13, 853, 10.1016\u002FS1097-2765(04)00131-5",{"doi":1206},"10.1016\u002FS1097-2765(04)00131-5",{"id":24,"text":1208,"url":24,"identifiers":1209},"Ho, 2005, Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells., Cancer Res, 65, 4273, 10.1158\u002F0008-5472.CAN-04-3494",{"doi":1210},"10.1158\u002F0008-5472.CAN-04-3494",{"id":24,"text":1212,"url":24,"identifiers":1213},"Bednarski, 2009, Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin., PLoS One, 4, e6992, 10.1371\u002Fjournal.pone.0006992",{"doi":1214},"10.1371\u002Fjournal.pone.0006992",{"id":24,"text":1216,"url":24,"identifiers":1217},"Tacar, 2013, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems., J Pharm Pharmacol, 65, 157, 10.1111\u002Fj.2042-7158.2012.01567.x",{"doi":1218},"10.1111\u002Fj.2042-7158.2012.01567.x",{"id":24,"text":1220,"url":24,"identifiers":1221},"Mendivil-Perez, 2012, TPEN induces apoptosis independently of zinc chelator activity in a model of acute lymphoblastic leukemia and ex vivo acute leukemia cells through oxidative stress and mitochondria caspase-3- and AIF-dependent pathways., Oxid Med Cell Longev, 2012, 313275, 10.1155\u002F2012\u002F313275",{"doi":1222},"10.1155\u002F2012\u002F313275",{"id":24,"text":1224,"url":24,"identifiers":1225},"Mendivil-Perez, 2014, Response to rotenone is glucose-sensitive in a model of human acute lymphoblastic leukemia: involvement of oxidative stress mechanism, DJ-1, Parkin, and PINK-1 proteins., Oxid Med Cell Longev, 2014, 457154, 10.1155\u002F2014\u002F457154",{"doi":1226},"10.1155\u002F2014\u002F457154",{"id":24,"text":1228,"url":24,"identifiers":1229},"Mendivil-Perez, 2013, Glucose starvation induces apoptosis in a model of acute T leukemia dependent on caspase-3 and apoptosis-inducing factor: a therapeutic strategy., Nutr Cancer, 65, 99, 10.1080\u002F01635581.2013.741751",{"doi":1230},"10.1080\u002F01635581.2013.741751",{"id":24,"text":1232,"url":24,"identifiers":1233},"Jimenez-Del-Rio, 2012, The bad, the good, and the ugly about oxidative stress., Oxid Med Cell Longev, 2012, 163913, 10.1155\u002F2012\u002F163913",{"doi":1234},"10.1155\u002F2012\u002F163913",{"id":24,"text":1236,"url":24,"identifiers":1237},"Winklhofer, 2014, Parkin and mitochondrial quality control: toward assembling the puzzle., Trends Cell Biol, 24, 332, 10.1016\u002Fj.tcb.2014.01.001",{"doi":1238},"10.1016\u002Fj.tcb.2014.01.001",{"id":24,"text":1240,"url":24,"identifiers":1241},"Yang, 2006, Induction of parkin expression in the presence of oxidative stress., Eur J Neurosci, 24, 1366, 10.1111\u002Fj.1460-9568.2006.04998.x",{"doi":1242},"10.1111\u002Fj.1460-9568.2006.04998.x",{"id":24,"text":1244,"url":24,"identifiers":1245},"Wilson, 2011, The role of cysteine oxidation in DJ-1 function and dysfunction., Antioxid Redox Signal, 15, 111, 10.1089\u002Fars.2010.3481",{"doi":1246},"10.1089\u002Fars.2010.3481",{"id":24,"text":1248,"url":24,"identifiers":1249},"Cookson, 2012, Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways., Cold Spring Harb Perspect Med, 2, a009415, 10.1101\u002Fcshperspect.a009415",{"doi":1250},"10.1101\u002Fcshperspect.a009415",{"id":24,"text":1252,"url":24,"identifiers":1253},"Liu, 2008, . Expression and role of DJ-1 in leukemia., Biochem Biophys Res Commun, 375, 477, 10.1016\u002Fj.bbrc.2008.08.046",{"doi":1254},"10.1016\u002Fj.bbrc.2008.08.046",{"id":24,"text":1256,"url":24,"identifiers":1257},"Agirre, 2006, . Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia., Int J Cancer, 118, 1945, 10.1002\u002Fijc.21584",{"doi":1258},"10.1002\u002Fijc.21584",{"id":24,"text":1260,"url":24,"identifiers":1261},"Zhang, 2011, . Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect., Proc Natl Acad Sci USA, 108, 16259, 10.1073\u002Fpnas.1113884108",{"doi":1262},"10.1073\u002Fpnas.1113884108",{"id":24,"text":1264,"url":24,"identifiers":1265},"Henn, 2007, . Parkin mediates neuroprotection through activation of IkappaB kinasenuclear factor-kappaB signaling., J Neurosci, 27, 1868, 10.1523\u002FJNEUROSCI.5537-06.2007",{"doi":1266},"10.1523\u002FJNEUROSCI.5537-06.2007",{"id":24,"text":1268,"url":24,"identifiers":1269},"Sha, 2010, Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling., Hum Mol Genet, 19, 352, 10.1093\u002Fhmg\u002Fddp501",{"doi":1270},"10.1093\u002Fhmg\u002Fddp501",{"id":24,"text":1272,"url":24,"identifiers":1273},"Fiegl, 2009, CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure., Blood, 113, 1504, 10.1182\u002Fblood-2008-06-161539",{"doi":1274},"10.1182\u002Fblood-2008-06-161539",{"id":24,"text":1276,"url":24,"identifiers":1277},"Ke, 2006, Hypoxia-inducible factor-1 (HIF-1)., Mol Pharmacol, 70, 1469, 10.1124\u002Fmol.106.027029",{"doi":1278},"10.1124\u002Fmol.106.027029",{"id":24,"text":1280,"url":24,"identifiers":1281},"Wu, 2011, Induction and testing of hypoxia in cell culture., J Vis Exp, 12, ii",{},{"id":24,"text":1283,"url":24,"identifiers":1284},"Marinho, 2014, Hydrogen peroxide sensing, signaling and regulation of transcription factors., Redox Biol, 2, 535, 10.1016\u002Fj.redox.2014.02.006",{"doi":1285},"10.1016\u002Fj.redox.2014.02.006",{"id":24,"text":1287,"url":24,"identifiers":1288},"Leite, 1999, Critical evaluation of techniques to detect and measure cell death - study in a model of UV radiation of the leukaemic cell line HL60., Anal Cell Pathol, 19, 139, 10.1155\u002F1999\u002F176515",{"doi":1289},"10.1155\u002F1999\u002F176515",{"id":24,"text":1291,"url":24,"identifiers":1292},"Mikami, 2006, . C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines., Anticancer Res, 26, 1153",{},{"id":24,"text":1294,"url":24,"identifiers":1295},"Inanami, 1999, Hydrogen peroxide-induced activation of SAPKJNK regulated by phosphatidylinositol 3-kinase in Chinese hamster V79 cells., Antioxid Redox Signal, 1, 113, 10.1089\u002Fars.1999.1.1-113",{"doi":1296},"10.1089\u002Fars.1999.1.1-113",{"id":24,"text":1298,"url":24,"identifiers":1299},"Kamata, 2002, Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops., FEBS Lett, 519, 231, 10.1016\u002FS0014-5793(02)02712-6",{"doi":1300},"10.1016\u002FS0014-5793(02)02712-6",{"id":24,"text":1302,"url":24,"identifiers":1303},"Takada, 2003, Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase., J Biol Chem, 278, 24233, 10.1074\u002Fjbc.M212389200",{"doi":1304},"10.1074\u002Fjbc.M212389200",{"id":24,"text":1306,"url":24,"identifiers":1307},"Yang, 2013, . Doxorubicin caused apoptosis of mesenchymal stem cells via p38, JNK and p53 pathway., Cell Physiol Biochem, 32, 1072, 10.1159\u002F000354507",{"doi":1308},"10.1159\u002F000354507",{"id":24,"text":1310,"url":24,"identifiers":1311},"McNeill-Blue, 2006, Apoptosis mediated by p53 in rat neural AF5 cells following treatment with hydrogen peroxide and staurosporine., Brain Res, 1112, 1, 10.1016\u002Fj.brainres.2006.07.024",{"doi":1312},"10.1016\u002Fj.brainres.2006.07.024",{"id":24,"text":1314,"url":24,"identifiers":1315},"Hangen, 2010, Life with or without AIF., Trends Biochem Sci, 35, 278, 10.1016\u002Fj.tibs.2009.12.008",{"doi":1316},"10.1016\u002Fj.tibs.2009.12.008",{"id":24,"text":1318,"url":24,"identifiers":1319},"Greene, 2012, . Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment., EMBO Rep, 13, 378, 10.1038\u002Fembor.2012.14",{"doi":1320},"10.1038\u002Fembor.2012.14",{"id":24,"text":1322,"url":24,"identifiers":1323},"Okatsu, 2012, . PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria., Nat Commun, 3, 1016, 10.1038\u002Fncomms2016",{"doi":1324},"10.1038\u002Fncomms2016",{"id":24,"text":1326,"url":24,"identifiers":1327},"Kondapalli, 2012, . PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65., Open Biol, 2, 120080, 10.1098\u002Frsob.120080",{"doi":1328},"10.1098\u002Frsob.120080",{"id":24,"text":1330,"url":24,"identifiers":1331},"Chan, 2011, Parkin uses the UPS to ship off dysfunctional mitochondria., Autophagy, 7, 771, 10.4161\u002Fauto.7.7.15453",{"doi":1332},"10.4161\u002Fauto.7.7.15453",{"id":24,"text":1334,"url":24,"identifiers":1335},"Benito, 2011, . Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104., PLoS One, 6, e23108, 10.1371\u002Fjournal.pone.0023108",{"doi":1336},"10.1371\u002Fjournal.pone.0023108",{"id":24,"text":1338,"url":24,"identifiers":1339},"Rohwer, 2010, . Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB., PLoS One, 5, e12038, 10.1371\u002Fjournal.pone.0012038",{"doi":1340},"10.1371\u002Fjournal.pone.0012038",{"id":1342,"createTime":1343,"updateTime":1343,"relativeEntities":1344,"slug":1345,"properties":1346,"entityType":202,"verifyStatus":460,"verifyTime":1343,"verifyNote":461,"syncStatus":23,"languages":1359,"translateLanguages":24,"viewCount":25,"primaryUrl":1360,"fullTextUrl":24,"authors":1361,"publicationType":278,"publisherRelationship":1445,"citationCount":70,"citationInfo":1482,"publishDate":1484,"publishYear":1485,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":1486,"isForceReanalyzing":441},"ce61a39b-eee7-4ca2-897e-f939e1ea6633","2024-10-06T22:12:25.897+00:00",[],"Relationship-of-mitochondrial-function-and-cellular-adenosine-triphosphate-levels-to-pMC540-and-merodantoin-cytotoxicity-in-MCF-7-human-breast-cancer-cells",{"mag":1347,"keywords":1349,"openalex":1350,"abstract":1352,"title":1353,"pm":1355,"doi":1357},{"VOID":1348},"2043983282",{},{"VOID":1351},"W2043983282",{},{"EN":1354},"Relationship of mitochondrial function and cellular adenosine triphosphate levels to pMC540 and merodantoin cytotoxicity in MCF-7 human breast cancer cells",{"VOID":1356},"7579558",{"VOID":1358},"10.1097\u002F00001813-199508000-00007",[205],"http:\u002F\u002Fjournals.lww.com\u002F00001813-199508000-00007",[1362,1383,1400,1415,1430],{"id":1363,"sortIndex":81,"researcher":24,"roles":1364,"affiliations":1365,"properties":1376},"08f3b517-e610-45e6-81b7-f419e47865a8",[],[1366],{"id":1367,"sortIndex":25,"affiliation":1368,"properties":24},"fcd45b42-4ee1-4112-8542-02a21c8a791d",{"id":1369,"createTime":1370,"updateTime":1370,"relativeEntities":1371,"slug":1372,"properties":1373,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"ac3859e1-4cff-4a15-a1d0-02cedda91589","2024-10-06T22:12:25.918+00:00",[],"820-2687",{"title":1374},{"EN":1375},"820–2687",{"openalex":1377,"orcid":1379,"title":1381},{"VOID":1378},"A5039661832",{"VOID":1380},"https:\u002F\u002Forcid.org\u002F0000-0002-2766-8671",{"EN":1382},"J. L. Matthews",{"id":1384,"sortIndex":79,"researcher":24,"roles":1385,"affiliations":1386,"properties":1393},"2e4246ca-329f-4cd5-b808-eaeea9e46f51",[],[1387],{"id":1388,"sortIndex":25,"affiliation":1389,"properties":24},"3411eb6a-b8c8-41cd-8736-e8581cf17983",{"id":1369,"createTime":1370,"updateTime":1370,"relativeEntities":1390,"slug":1372,"properties":1391,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1392},{"EN":1375},{"openalex":1394,"orcid":1396,"title":1398},{"VOID":1395},"A5088412261",{"VOID":1397},"https:\u002F\u002Forcid.org\u002F0000-0002-7291-4907",{"EN":1399},"Lauren Ruger",{"id":1401,"sortIndex":78,"researcher":24,"roles":1402,"affiliations":1403,"properties":1410},"4d157ed1-f345-44d1-b02d-b0bf1232ea97",[],[1404],{"id":1405,"sortIndex":25,"affiliation":1406,"properties":24},"a35043aa-d9b6-4c12-a9cd-264fcee1a10c",{"id":1369,"createTime":1370,"updateTime":1370,"relativeEntities":1407,"slug":1372,"properties":1408,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1409},{"EN":1375},{"openalex":1411,"title":1413},{"VOID":1412},"A5072648664",{"EN":1414},"Radhakant Sharma",{"id":1416,"sortIndex":80,"researcher":24,"roles":1417,"affiliations":1418,"properties":1425},"a4372b02-dae6-4fe7-aa06-5cd27196c274",[],[1419],{"id":1420,"sortIndex":25,"affiliation":1421,"properties":24},"a0fd139e-c8bf-455a-917e-80de8986db81",{"id":1369,"createTime":1370,"updateTime":1370,"relativeEntities":1422,"slug":1372,"properties":1423,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1424},{"EN":1375},{"openalex":1426,"title":1428},{"VOID":1427},"A5089918681",{"EN":1429},"Hwan-Wun Liu",{"id":1431,"sortIndex":25,"researcher":24,"roles":1432,"affiliations":1433,"properties":1440},"9f79e80b-39ea-4878-acdd-bd4566863d43",[],[1434],{"id":1435,"sortIndex":25,"affiliation":1436,"properties":24},"68580471-794c-46dc-b6b9-2003fc8a8090",{"id":1369,"createTime":1370,"updateTime":1370,"relativeEntities":1437,"slug":1372,"properties":1438,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1439},{"EN":1375},{"openalex":1441,"title":1443},{"VOID":1442},"A5004675343",{"EN":1444},"Kirpal S. Gulliya",{"url":24,"publisher":1446,"properties":1476},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1447,"slug":10,"properties":1448,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1454,"manageAffiliations":1455,"indexDatabases":1456,"url":165,"thumbnailPath":24,"statistic":1471,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1449,"issn":1450,"introduce":1451,"eissn":1452,"title":1453},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[1457,1464],{"id":124,"indexDatabase":1458,"url":137,"indexYears":138,"academicFieldIds":1463,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":1459,"label":1460,"description":1461,"key":134,"publicationTags":1462,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":1465,"url":161,"indexYears":24,"academicFieldIds":1470,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":1466,"label":1467,"description":1468,"key":157,"publicationTags":1469,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":1472,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":1473,"totalCitation":170,"totalCitationByYear":1474,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":1475,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":1477,"pages":1478,"issue":1480},{"VOID":1110},{"VOID":1479},"545-552",{"VOID":1481},"4",{"total":70,"publishYear":24,"statisticByYear":1483},{"2016":78},"1995-08-01",1995,[],{"id":1488,"createTime":1489,"updateTime":1489,"relativeEntities":1490,"slug":1491,"properties":1492,"entityType":202,"verifyStatus":460,"verifyTime":1489,"verifyNote":461,"syncStatus":23,"languages":1505,"translateLanguages":24,"viewCount":25,"primaryUrl":1506,"fullTextUrl":24,"authors":1507,"publicationType":278,"publisherRelationship":1648,"citationCount":1684,"citationInfo":1685,"publishDate":1687,"publishYear":322,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":1688,"isForceReanalyzing":441},"d379dbd2-6e96-45a3-a297-9f8e209796be","2025-01-24T21:21:49.149+00:00",[],"The-antipsychotic-drug-chlorpromazine-enhances-the-cytotoxic-effect-of-tamoxifen-in-tamoxifen-sensitive-and-tamoxifen-resistant-human-breast-cancer-cells",{"mag":1493,"keywords":1495,"openalex":1496,"abstract":1498,"title":1499,"pm":1501,"doi":1503},{"VOID":1494},"1978473293",{},{"VOID":1497},"W1978473293",{},{"EN":1500},"The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells",{"VOID":1502},"19584708",{"VOID":1504},"10.1097\u002Fcad.0b013e32832ec041",[205],"https:\u002F\u002Fjournals.lww.com\u002F00001813-200909000-00010",[1508,1540,1561,1581,1604,1627],{"id":1509,"sortIndex":82,"researcher":24,"roles":1510,"affiliations":1511,"properties":1533},"79a8715d-667d-40b4-84e3-08cb4f2f63d1",[],[1512,1523],{"id":1513,"sortIndex":25,"affiliation":1514,"properties":24},"9d4dc1c1-1c59-4788-8bf3-aaeb81e48215",{"id":1515,"createTime":1516,"updateTime":1517,"relativeEntities":1518,"slug":1519,"properties":1520,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"89b7bc97-ddba-426e-8d9b-99b3e0b80d87","2024-01-05T12:02:37.444+00:00","2025-02-08T04:33:38.058+00:00",[],"Biochemistry-and-Molecular-Biology",{"title":1521},{"VI":1522},"Biochemistry and Molecular Biology",{"id":1524,"sortIndex":78,"affiliation":1525,"properties":24},"b4ef69bd-809a-48c4-b83b-150615344047",{"id":1526,"createTime":1527,"updateTime":1527,"relativeEntities":1528,"slug":1529,"properties":1530,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"6d5f61bb-b044-4160-94c5-79619c6b7eba","2025-01-24T21:21:49.224+00:00",[],"to-Associate-Professor-Barbara-Guerra-Department-of-Biochemistry-and-Molecular-Biology-University-of-Southern-Denmark-Campusvej-55-DK-5230-Odense-Denmark",{"title":1531},{"EN":1532},"to Associate Professor Barbara Guerra, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230, Odense, Denmark",{"openalex":1534,"orcid":1536,"title":1538},{"VOID":1535},"A5079460105",{"VOID":1537},"https:\u002F\u002Forcid.org\u002F0000-0003-1136-2413",{"EN":1539},"Bárbara Guerra",{"id":1541,"sortIndex":81,"researcher":24,"roles":1542,"affiliations":1543,"properties":1554},"958b5317-cb2f-41a2-bc12-4c9a863146a0",[],[1544],{"id":1545,"sortIndex":25,"affiliation":1546,"properties":24},"846ded29-e463-408b-a21a-449db9623a33",{"id":1547,"createTime":1548,"updateTime":1548,"relativeEntities":1549,"slug":1550,"properties":1551,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"e8fc527f-b8c3-49fe-92dd-65b5dc3c0559","2025-01-24T21:21:49.183+00:00",[],"Physics-and-Chemistry-Center-for-Biomembrane-Physics-MEMPHYS-University-of-Southern-Denmark-Odense",{"title":1552},{"EN":1553},"Physics and Chemistry, Center for Biomembrane Physics (MEMPHYS), University of Southern Denmark, Odense",{"openalex":1555,"orcid":1557,"title":1559},{"VOID":1556},"A5017893762",{"VOID":1558},"https:\u002F\u002Forcid.org\u002F0000-0002-4258-8960",{"EN":1560},"Ole G. Mouritsen",{"id":1562,"sortIndex":79,"researcher":24,"roles":1563,"affiliations":1564,"properties":1576},"6ff1969e-cdbc-4aa1-be2f-7c9869a972d6",[],[1565],{"id":1566,"sortIndex":25,"affiliation":1567,"properties":24},"ecab2d52-81c1-4364-a085-7853fbc5f49b",{"id":1568,"createTime":1569,"updateTime":1570,"relativeEntities":1571,"slug":1572,"properties":1573,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"1e40db1b-6107-4a7a-8cb6-7a9da3c8a079","2024-01-08T21:53:18.386+00:00","2025-01-24T21:21:49.171+00:00",[],"Department-of-Tumor-Endocrinology-Institute-of-Cancer-Biology-Danish-Cancer-Society-Copenhagen-Denmark",{"title":1574},{"VI":1575},"Department of Tumor Endocrinology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark",{"openalex":1577,"title":1579},{"VOID":1578},"A5001854115",{"EN":1580},"Anne E. Lykkesfeldt",{"id":1582,"sortIndex":78,"researcher":24,"roles":1583,"affiliations":1584,"properties":1597},"57a47cb6-0307-4194-a4b3-2fa59f02b36a",[],[1585,1591],{"id":1586,"sortIndex":25,"affiliation":1587,"properties":24},"3ee9ad18-6c33-4c40-8ae3-f575376473cc",{"id":1515,"createTime":1516,"updateTime":1517,"relativeEntities":1588,"slug":1519,"properties":1589,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1590},{"VI":1522},{"id":1592,"sortIndex":78,"affiliation":1593,"properties":24},"141444fd-37fb-4b7e-b6ee-06ea95fa866f",{"id":1547,"createTime":1548,"updateTime":1548,"relativeEntities":1594,"slug":1550,"properties":1595,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1596},{"EN":1553},{"openalex":1598,"orcid":1600,"title":1602},{"VOID":1599},"A5033116626",{"VOID":1601},"https:\u002F\u002Forcid.org\u002F0000-0003-1196-6241",{"EN":1603},"Mathias P. Clausen",{"id":1605,"sortIndex":25,"researcher":24,"roles":1606,"affiliations":1607,"properties":1620},"3b4c9aa3-653e-4e4b-91a9-6d3c04d5dc90",[],[1608,1614],{"id":1609,"sortIndex":25,"affiliation":1610,"properties":24},"edf916c5-c3ac-4de9-9932-cee9d55efc2b",{"id":1515,"createTime":1516,"updateTime":1517,"relativeEntities":1611,"slug":1519,"properties":1612,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1613},{"VI":1522},{"id":1615,"sortIndex":78,"affiliation":1616,"properties":24},"908e1e7c-358c-443f-b9ce-6fa15881fd33",{"id":1568,"createTime":1569,"updateTime":1570,"relativeEntities":1617,"slug":1572,"properties":1618,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1619},{"VI":1575},{"openalex":1621,"orcid":1623,"title":1625},{"VOID":1622},"A5017762827",{"VOID":1624},"https:\u002F\u002Forcid.org\u002F0000-0001-9578-9136",{"EN":1626},"Christina W. Yde",{"id":1628,"sortIndex":80,"researcher":24,"roles":1629,"affiliations":1630,"properties":1643},"60fb23a3-4469-4848-9942-58aca3f1e990",[],[1631,1637],{"id":1632,"sortIndex":25,"affiliation":1633,"properties":24},"1338c0f9-6a78-4c0c-8b12-2f86801885a8",{"id":1515,"createTime":1516,"updateTime":1517,"relativeEntities":1634,"slug":1519,"properties":1635,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1636},{"VI":1522},{"id":1638,"sortIndex":78,"affiliation":1639,"properties":24},"b14dcbbb-2e78-4034-8bab-b79eadd83e9c",{"id":1547,"createTime":1548,"updateTime":1548,"relativeEntities":1640,"slug":1550,"properties":1641,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1642},{"EN":1553},{"openalex":1644,"title":1646},{"VOID":1645},"A5024910225",{"EN":1647},"Martin V. Bennetzen",{"url":24,"publisher":1649,"properties":1679},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1650,"slug":10,"properties":1651,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1657,"manageAffiliations":1658,"indexDatabases":1659,"url":165,"thumbnailPath":24,"statistic":1674,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1652,"issn":1653,"introduce":1654,"eissn":1655,"title":1656},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[1660,1667],{"id":124,"indexDatabase":1661,"url":137,"indexYears":138,"academicFieldIds":1666,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":1662,"label":1663,"description":1664,"key":134,"publicationTags":1665,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":1668,"url":161,"indexYears":24,"academicFieldIds":1673,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":1669,"label":1670,"description":1671,"key":157,"publicationTags":1672,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":1675,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":1676,"totalCitation":170,"totalCitationByYear":1677,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":1678,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":1680,"pages":1681,"issue":1683},{"VOID":312},{"VOID":1682},"723-735",{"VOID":523},64,{"total":1684,"publishYear":24,"statisticByYear":1686},{"2012":81,"2013":81,"2014":80,"2015":168,"2016":80,"2017":82,"2018":81,"2019":82,"2020":168,"2021":81,"2022":82,"2023":80,"2024":70},"2009-09-01",[1689,1693,1697,1701,1704,1708,1712,1716,1720,1723,1727,1731,1735,1739,1743,1747,1751,1755,1758,1762,1766,1770,1774,1778,1782,1786,1790,1794,1798,1802,1806,1810,1814,1817,1821,1825,1829,1833,1837,1841,1845,1849],{"id":24,"text":1690,"url":24,"identifiers":1691},"Lykkesfeldt, 1996, Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer, Acta Oncol, 35, 9, 10.3109\u002F02841869609083961",{"doi":1692},"10.3109\u002F02841869609083961",{"id":24,"text":1694,"url":24,"identifiers":1695},"Nicholson, 2005, Endocrine therapy – current benefits and limitations, Breast Cancer Res Treat, 93, S3, 10.1007\u002Fs10549-005-9036-4",{"doi":1696},"10.1007\u002Fs10549-005-9036-4",{"id":24,"text":1698,"url":24,"identifiers":1699},"Riggins, 2007, Pathways to tamoxifen resistance, Cancer Lett, 256, 1, 10.1016\u002Fj.canlet.2007.03.016",{"doi":1700},"10.1016\u002Fj.canlet.2007.03.016",{"id":24,"text":1702,"url":24,"identifiers":1703},"Adams, 2007, Chlorpromazine versus placebo for schizophrenia, Cochrane Database Syst Rev, 2, CD000284",{},{"id":24,"text":1705,"url":24,"identifiers":1706},"Garver, 2006, Evolution of antipsychotic intervention in the schizophrenic psychosis, Curr Drug Targets, 7, 1205, 10.2174\u002F138945006778226543",{"doi":1707},"10.2174\u002F138945006778226543",{"id":24,"text":1709,"url":24,"identifiers":1710},"Muraoka, 2003, Inactivation of cholinesterase induced by chlorpromazine cation radicals, Pharmacol Toxicol, 92, 100, 10.1034\u002Fj.1600-0773.2003.920207.x",{"doi":1711},"10.1034\u002Fj.1600-0773.2003.920207.x",{"id":24,"text":1713,"url":24,"identifiers":1714},"Sato, 1995, Pharmacokinetic analysis of chlorpromazine in rat serum, cerebrospinal fluid and striatum, Biol Pharm Bull, 18, 593, 10.1248\u002Fbpb.18.593",{"doi":1715},"10.1248\u002Fbpb.18.593",{"id":24,"text":1717,"url":24,"identifiers":1718},"Zhelev, 2004, Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia, Cancer Chemother Pharmacol, 53, 267, 10.1007\u002Fs00280-003-0738-1",{"doi":1719},"10.1007\u002Fs00280-003-0738-1",{"id":24,"text":1721,"url":24,"identifiers":1722},"Gil-Ad, 2006, Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth, Oncol Rep, 15, 107",{},{"id":24,"text":1724,"url":24,"identifiers":1725},"Nordenberg, 1999, Effects of psychotropic drugs on cell proliferation and differentiation, Biochem Pharmacol, 58, 1229, 10.1016\u002FS0006-2952(99)00156-2",{"doi":1726},"10.1016\u002FS0006-2952(99)00156-2",{"id":24,"text":1728,"url":24,"identifiers":1729},"Martins, 2008, Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities, Int J Antimicrob Agents, 31, 198, 10.1016\u002Fj.ijantimicag.2007.10.025",{"doi":1730},"10.1016\u002Fj.ijantimicag.2007.10.025",{"id":24,"text":1732,"url":24,"identifiers":1733},"Tsakovska, 2006, Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance, Curr Drug Targets, 7, 1123, 10.2174\u002F138945006778226660",{"doi":1734},"10.2174\u002F138945006778226660",{"id":24,"text":1736,"url":24,"identifiers":1737},"Ford, 1993, Pharmacologic circumvention of multidrug resistance, Cytotechnology, 12, 171, 10.1007\u002FBF00744664",{"doi":1738},"10.1007\u002FBF00744664",{"id":24,"text":1740,"url":24,"identifiers":1741},"Michalak, 2006, Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal, Curr Drug Targets, 7, 1095, 10.2174\u002F138945006778226570",{"doi":1742},"10.2174\u002F138945006778226570",{"id":24,"text":1744,"url":24,"identifiers":1745},"Callaghan, 1995, Interaction of tamoxifen with the multidrug resistance P-glycoprotein, Br J Cancer, 71, 294, 10.1038\u002Fbjc.1995.59",{"doi":1746},"10.1038\u002Fbjc.1995.59",{"id":24,"text":1748,"url":24,"identifiers":1749},"Kayyali, 1994, Tamoxifen decreases drug efflux from liposomes: relevance to its ability to reverse multidrug resistance in cancer cells?, FEBS Lett, 344, 221, 10.1016\u002F0014-5793(94)00378-5",{"doi":1750},"10.1016\u002F0014-5793(94)00378-5",{"id":24,"text":1752,"url":24,"identifiers":1753},"Lykkesfeldt, 1992, Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1, Acta Oncol, 31, 131, 10.3109\u002F02841869209088892",{"doi":1754},"10.3109\u002F02841869209088892",{"id":24,"text":1756,"url":24,"identifiers":1757},"Lykkesfeldt, 1994, Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7\u002FTAMR-1, Cancer Res, 54, 1587",{},{"id":24,"text":1759,"url":24,"identifiers":1760},"De Cremoux, 2003, Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens, Endocr Relat Cancer, 10, 409, 10.1677\u002Ferc.0.0100409",{"doi":1761},"10.1677\u002Ferc.0.0100409",{"id":24,"text":1763,"url":24,"identifiers":1764},"Lundholt, 2001, Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways, Breast Cancer Res Treat, 67, 199, 10.1023\u002FA:1017977406429",{"doi":1765},"10.1023\u002FA:1017977406429",{"id":24,"text":1767,"url":24,"identifiers":1768},"Yde, 2007, Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death, Mol Cancer Ther, 6, 1869, 10.1158\u002F1535-7163.MCT-07-0072",{"doi":1769},"10.1158\u002F1535-7163.MCT-07-0072",{"id":24,"text":1771,"url":24,"identifiers":1772},"Heerklotz, 2000, Titration calorimetry of surfactant-membrane partitioning and membrane solubilization, Biochim Biophys Acta, 1508, 69, 10.1016\u002FS0304-4157(00)00009-5",{"doi":1773},"10.1016\u002FS0304-4157(00)00009-5",{"id":24,"text":1775,"url":24,"identifiers":1776},"Leidy, 2006, Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition, Biophys J, 90, 3165, 10.1529\u002Fbiophysj.105.070987",{"doi":1777},"10.1529\u002Fbiophysj.105.070987",{"id":24,"text":1779,"url":24,"identifiers":1780},"Drori, 1995, Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability, Eur J Biochem, 228, 1020, 10.1111\u002Fj.1432-1033.1995.tb20352.x",{"doi":1781},"10.1111\u002Fj.1432-1033.1995.tb20352.x",{"id":24,"text":1783,"url":24,"identifiers":1784},"Jørgensen, 1991, A general model for the interaction of foreign molecules with lipid membranes: drugs and anaesthetics, Biochim Biophys Acta, 1062, 227, 10.1016\u002F0005-2736(91)90397-Q",{"doi":1785},"10.1016\u002F0005-2736(91)90397-Q",{"id":24,"text":1787,"url":24,"identifiers":1788},"Agasøsler, 2001, Chlorpromazine-induced increase in dipalmitoylphosphatidylserine surface area in monolayers at room temperature, Biochem Pharmacol, 61, 817, 10.1016\u002FS0006-2952(01)00542-1",{"doi":1789},"10.1016\u002FS0006-2952(01)00542-1",{"id":24,"text":1791,"url":24,"identifiers":1792},"Trandum, 1999, Association of ethanol with lipid membranes containing cholesterol, sphingomyelin and ganglioside: a titration calorimetry study, Biochim Biophys Acta, 1420, 179, 10.1016\u002FS0005-2736(99)00092-9",{"doi":1793},"10.1016\u002FS0005-2736(99)00092-9",{"id":24,"text":1795,"url":24,"identifiers":1796},"Wisniewska, 2004, ESR studies on the effect of cholesterol on chlorpromazine interaction with saturated and unsaturated liposome membranes, Biophys Chem, 111, 43, 10.1016\u002Fj.bpc.2004.04.001",{"doi":1797},"10.1016\u002Fj.bpc.2004.04.001",{"id":24,"text":1799,"url":24,"identifiers":1800},"Ali, 2002, Endocrine-responsive breast cancer and strategies for combating resistance, Nat Rev Cancer, 2, 101, 10.1038\u002Fnrc721",{"doi":1801},"10.1038\u002Fnrc721",{"id":24,"text":1803,"url":24,"identifiers":1804},"Phillips, 2001, Understanding the genotoxicity of tamoxifen?, Carcinogenesis, 22, 839, 10.1093\u002Fcarcin\u002F22.6.839",{"doi":1805},"10.1093\u002Fcarcin\u002F22.6.839",{"id":24,"text":1807,"url":24,"identifiers":1808},"Wozniak, 2007, The DNA-damaging potential of tamoxifen in breast cancer and normal cells, Arch Toxicol, 81, 519, 10.1007\u002Fs00204-007-0188-3",{"doi":1809},"10.1007\u002Fs00204-007-0188-3",{"id":24,"text":1811,"url":24,"identifiers":1812},"Bland, 2008, Relationship between tamoxifen use and high risk endometrial cancer histologic types, Gynecol Oncol, 112, 150, 10.1016\u002Fj.ygyno.2008.08.035",{"doi":1813},"10.1016\u002Fj.ygyno.2008.08.035",{"id":24,"text":1815,"url":24,"identifiers":1816},"Morgan, 1997, Risk of endometrial cancer after tamoxifen treatment, Oncology (Huntingt), 11, 25",{},{"id":24,"text":1818,"url":24,"identifiers":1819},"Clarke, 1990, Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol, J Natl Cancer Inst, 82, 1702, 10.1093\u002Fjnci\u002F82.21.1702",{"doi":1820},"10.1093\u002Fjnci\u002F82.21.1702",{"id":24,"text":1822,"url":24,"identifiers":1823},"Zeisig, 2007, Increase in fluidity in the membrane of MT3 breast cancer cells correlates with enhanced cell adhesion in vitro and increased lung metastasis in NOD\u002FSCID mice, Arch Biochem Biophys, 459, 98, 10.1016\u002Fj.abb.2006.09.030",{"doi":1824},"10.1016\u002Fj.abb.2006.09.030",{"id":24,"text":1826,"url":24,"identifiers":1827},"Bursch, 1996, Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy, Carcinogenesis, 17, 1595, 10.1093\u002Fcarcin\u002F17.8.1595",{"doi":1828},"10.1093\u002Fcarcin\u002F17.8.1595",{"id":24,"text":1830,"url":24,"identifiers":1831},"Moreira, 2006, Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure, J Biol Chem, 281, 10143, 10.1074\u002Fjbc.M510249200",{"doi":1832},"10.1074\u002Fjbc.M510249200",{"id":24,"text":1834,"url":24,"identifiers":1835},"Frogne, 2009, Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant, Breast Cancer Res Treat, 114, 263, 10.1007\u002Fs10549-008-0011-8",{"doi":1836},"10.1007\u002Fs10549-008-0011-8",{"id":24,"text":1838,"url":24,"identifiers":1839},"Frogne, 2005, Antiestrogen-resistant human breast cancer cells require activated protein kinase B\u002FAkt for growth, Endocr Relat Cancer, 12, 599, 10.1677\u002Ferc.1.00946",{"doi":1840},"10.1677\u002Ferc.1.00946",{"id":24,"text":1842,"url":24,"identifiers":1843},"Yde, 2007, Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT, Cancer Lett, 256, 229, 10.1016\u002Fj.canlet.2007.06.010",{"doi":1844},"10.1016\u002Fj.canlet.2007.06.010",{"id":24,"text":1846,"url":24,"identifiers":1847},"Broniec, 2007, Trifluoperazine causes a disturbance in glycerophospholipid monolayers containing phosphatidylserine (PS): effects of pH, acyl unsaturation, and proportion of PS, Langmuir, 23, 694, 10.1021\u002Fla061628b",{"doi":1848},"10.1021\u002Fla061628b",{"id":24,"text":1850,"url":24,"identifiers":1851},"Wesolowska, 2004, Presence of anionic phospholipids rules the membrane localization of phenothiazine type multidrug resistance modulator, Biophys Chem, 109, 399, 10.1016\u002Fj.bpc.2003.11.004",{"doi":1852},"10.1016\u002Fj.bpc.2003.11.004",{"id":1854,"createTime":1855,"updateTime":1855,"relativeEntities":1856,"slug":1857,"properties":1858,"entityType":202,"verifyStatus":460,"verifyTime":1855,"verifyNote":461,"syncStatus":23,"languages":1867,"translateLanguages":24,"viewCount":25,"primaryUrl":1868,"fullTextUrl":24,"authors":1869,"publicationType":278,"publisherRelationship":1891,"citationCount":1928,"citationInfo":1929,"publishDate":1931,"publishYear":1932,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":1933,"isForceReanalyzing":441},"c9c61381-070f-49bf-9664-cfad94090554","2025-01-31T21:01:21.425+00:00",[],"Hypothalamic-hormones",{"keywords":1859,"openalex":1860,"abstract":1862,"title":1863,"doi":1865},{},{"VOID":1861},"W4300471801",{},{"EN":1864},"Hypothalamic hormones",{"VOID":1866},"10.1097\u002F00001813-199404000-00001",[205],"http:\u002F\u002Fjournals.lww.com\u002F00001813-199404000-00001",[1870],{"id":1871,"sortIndex":25,"researcher":24,"roles":1872,"affiliations":1873,"properties":1884},"f0a9ca26-9004-4ce6-bc4b-d697867303ea",[],[1874],{"id":1875,"sortIndex":25,"affiliation":1876,"properties":24},"a00d2f8d-7153-4566-9440-5f4cd6924740",{"id":1877,"createTime":1878,"updateTime":1878,"relativeEntities":1879,"slug":1880,"properties":1881,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"c5a7c8d7-318c-45e4-b19c-27e26accabd6","2025-01-31T21:01:21.455+00:00",[],"Endocrine-Polypeptide-and-Cancer-Institute-Veterans-Affairs-Medical-Center-New-Orleans-LA-701-46-and-Section-of-Experimental-Medicine-Department-of-Medicine-Tulane-University-Medical-School-New-Orleans-LA-70112-USA-",{"title":1882},{"EN":1883},"Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, New Orleans, LA 701 46, and Section of Experimental Medicine, Department of Medicine, Tulane University Medical School, New Orleans, LA 70112, USA.",{"openalex":1885,"orcid":1887,"title":1889},{"VOID":1886},"A5068739269",{"VOID":1888},"https:\u002F\u002Forcid.org\u002F0000-0003-1273-6747",{"EN":1890},"Andrew V. Schally",{"url":24,"publisher":1892,"properties":1922},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1893,"slug":10,"properties":1894,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1900,"manageAffiliations":1901,"indexDatabases":1902,"url":165,"thumbnailPath":24,"statistic":1917,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1895,"issn":1896,"introduce":1897,"eissn":1898,"title":1899},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[1903,1910],{"id":124,"indexDatabase":1904,"url":137,"indexYears":138,"academicFieldIds":1909,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":1905,"label":1906,"description":1907,"key":134,"publicationTags":1908,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":1911,"url":161,"indexYears":24,"academicFieldIds":1916,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":1912,"label":1913,"description":1914,"key":157,"publicationTags":1915,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":1918,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":1919,"totalCitation":170,"totalCitationByYear":1920,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":1921,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":1923,"pages":1924,"issue":1926},{"VOID":316},{"VOID":1925},"115-130",{"VOID":1927},"2",32,{"total":1928,"publishYear":24,"statisticByYear":1930},{"2016":78,"2024":78},"1994-04-01",1994,[],{"id":1935,"createTime":1936,"updateTime":1936,"relativeEntities":1937,"slug":1938,"properties":1939,"entityType":202,"verifyStatus":460,"verifyTime":1936,"verifyNote":461,"syncStatus":23,"languages":1952,"translateLanguages":24,"viewCount":25,"primaryUrl":1953,"fullTextUrl":24,"authors":1954,"publicationType":278,"publisherRelationship":2127,"citationCount":2164,"citationInfo":2165,"publishDate":2167,"publishYear":2168,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":2169,"isForceReanalyzing":441},"b55366be-2cbf-4852-b2c9-11d8a555550d","2024-09-21T20:45:02.457+00:00",[],"Safety-activity-and-estrogen-inhibition-by-exemestane-in-postmenopausal-women-with-advanced-breast-cancer-a-phase-I-study",{"mag":1940,"keywords":1942,"openalex":1943,"abstract":1945,"title":1946,"pm":1948,"doi":1950},{"VOID":1941},"2069646337",{},{"VOID":1944},"W2069646337",{},{"EN":1947},"Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study",{"VOID":1949},"9823425",{"VOID":1951},"10.1097\u002F00001813-199809000-00002",[205],"http:\u002F\u002Fjournals.lww.com\u002F00001813-199809000-00002",[1955,1974,1991,2006,2021,2037,2052,2067,2082,2097,2112],{"id":1956,"sortIndex":1957,"researcher":24,"roles":1958,"affiliations":1959,"properties":1969},"7cf1d551-bba3-45fe-adf5-68acb257dea1",9,[],[1960],{"id":1961,"sortIndex":25,"affiliation":1962,"properties":24},"14191634-5ecb-4c28-9f73-b80fa8e38842",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":1965,"slug":1966,"properties":1967,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"9ea140cd-3b42-4a58-9829-747ff150f7f4","2024-09-21T20:45:02.475+00:00",[],"02",{"title":1968},{"EN":1966},{"openalex":1970,"title":1972},{"VOID":1971},"A5017925719",{"EN":1973},"Silvana Lanzalone",{"id":1975,"sortIndex":78,"researcher":24,"roles":1976,"affiliations":1977,"properties":1984},"02bb9047-8728-4a61-ab29-aae1800c4cd5",[],[1978],{"id":1979,"sortIndex":25,"affiliation":1980,"properties":24},"2cd42118-4fb1-4b81-86fc-9dd7590b6256",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":1981,"slug":1966,"properties":1982,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":1983},{"EN":1966},{"openalex":1985,"orcid":1987,"title":1989},{"VOID":1986},"A5081216142",{"VOID":1988},"https:\u002F\u002Forcid.org\u002F0000-0002-6832-6467",{"EN":1990},"José Thomas",{"id":1992,"sortIndex":82,"researcher":24,"roles":1993,"affiliations":1994,"properties":2001},"a31ebcac-116f-43cb-a9e5-45bdb12c9f54",[],[1995],{"id":1996,"sortIndex":25,"affiliation":1997,"properties":24},"36fd2d5b-929b-4f51-8166-4093324a244e",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":1998,"slug":1966,"properties":1999,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2000},{"EN":1966},{"openalex":2002,"title":2004},{"VOID":2003},"A5032213495",{"EN":2005},"E. Di Salle",{"id":2007,"sortIndex":80,"researcher":24,"roles":2008,"affiliations":2009,"properties":2016},"eafa2a8e-a525-44b5-97af-1b98cd3f68b2",[],[2010],{"id":2011,"sortIndex":25,"affiliation":2012,"properties":24},"3009a41c-caa5-475c-8f0d-72ff90b3adb1",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":2013,"slug":1966,"properties":2014,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2015},{"EN":1966},{"openalex":2017,"title":2019},{"VOID":2018},"A5079463175",{"EN":2020},"J. Wildiers",{"id":2022,"sortIndex":2023,"researcher":24,"roles":2024,"affiliations":2025,"properties":2032},"479c2e4a-7ce6-47a0-a238-b5fd04e3ac81",10,[],[2026],{"id":2027,"sortIndex":25,"affiliation":2028,"properties":24},"c4ba1e70-b547-4e81-94cc-608eb2914bc1",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":2029,"slug":1966,"properties":2030,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2031},{"EN":1966},{"openalex":2033,"title":2035},{"VOID":2034},"A5091859796",{"EN":2036},"K de Belder",{"id":2038,"sortIndex":81,"researcher":24,"roles":2039,"affiliations":2040,"properties":2047},"6d090448-fadd-4719-bf64-9adae4c8a4b6",[],[2041],{"id":2042,"sortIndex":25,"affiliation":2043,"properties":24},"31df013f-c09c-4360-b649-c11ee74c4f24",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":2044,"slug":1966,"properties":2045,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2046},{"EN":1966},{"openalex":2048,"title":2050},{"VOID":2049},"A5081392983",{"EN":2051},"Jean‐Pierre Lobelle",{"id":2053,"sortIndex":70,"researcher":24,"roles":2054,"affiliations":2055,"properties":2062},"1a7d2540-17bd-4654-840f-2cc461b44ff9",[],[2056],{"id":2057,"sortIndex":25,"affiliation":2058,"properties":24},"a3aa9d8b-394e-409a-acb0-736bb7628001",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":2059,"slug":1966,"properties":2060,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2061},{"EN":1966},{"openalex":2063,"title":2065},{"VOID":2064},"A5104111699",{"EN":2066},"M.Z. Matteo Zurlo",{"id":2068,"sortIndex":168,"researcher":24,"roles":2069,"affiliations":2070,"properties":2077},"6d8f8614-d044-422f-b2a2-3ac047e53f09",[],[2071],{"id":2072,"sortIndex":25,"affiliation":2073,"properties":24},"0ac66021-5168-4d53-9db8-50cd1a9633b2",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":2074,"slug":1966,"properties":2075,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2076},{"EN":1966},{"openalex":2078,"title":2080},{"VOID":2079},"A5056174087",{"EN":2081},"G. Ornati",{"id":2083,"sortIndex":320,"researcher":24,"roles":2084,"affiliations":2085,"properties":2092},"930d54d9-601d-48e6-ae45-cc15bfc405ae",[],[2086],{"id":2087,"sortIndex":25,"affiliation":2088,"properties":24},"10c92dc1-6c1a-4de2-8145-2bbc326a1ac0",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":2089,"slug":1966,"properties":2090,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2091},{"EN":1966},{"openalex":2093,"title":2095},{"VOID":2094},"A5083634538",{"EN":2096},"Anna Polli",{"id":2098,"sortIndex":79,"researcher":24,"roles":2099,"affiliations":2100,"properties":2107},"d540254a-6ef5-42e0-be4a-4c5a7f84d4dd",[],[2101],{"id":2102,"sortIndex":25,"affiliation":2103,"properties":24},"21c1950c-9e45-453b-9c6c-7133681b851c",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":2104,"slug":1966,"properties":2105,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2106},{"EN":1966},{"openalex":2108,"title":2110},{"VOID":2109},"A5009550058",{"EN":2111},"P. Vermeiren",{"id":2113,"sortIndex":25,"researcher":24,"roles":2114,"affiliations":2115,"properties":2122},"4d14aad2-d67e-4e27-b90f-4da151b8f1e2",[],[2116],{"id":2117,"sortIndex":25,"affiliation":2118,"properties":24},"00cda177-f597-493d-a30f-d2090b71b97c",{"id":1963,"createTime":1964,"updateTime":1964,"relativeEntities":2119,"slug":1966,"properties":2120,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2121},{"EN":1966},{"openalex":2123,"title":2125},{"VOID":2124},"A5001188276",{"EN":2126},"Robert Paridaens",{"url":24,"publisher":2128,"properties":2158},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2129,"slug":10,"properties":2130,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2136,"manageAffiliations":2137,"indexDatabases":2138,"url":165,"thumbnailPath":24,"statistic":2153,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2131,"issn":2132,"introduce":2133,"eissn":2134,"title":2135},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[2139,2146],{"id":124,"indexDatabase":2140,"url":137,"indexYears":138,"academicFieldIds":2145,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":2141,"label":2142,"description":2143,"key":134,"publicationTags":2144,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":2147,"url":161,"indexYears":24,"academicFieldIds":2152,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":2148,"label":2149,"description":2150,"key":157,"publicationTags":2151,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":2154,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":2155,"totalCitation":170,"totalCitationByYear":2156,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":2157,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":2159,"pages":2161,"issue":2163},{"VOID":2160},"9",{"VOID":2162},"675-683",{"VOID":523},38,{"total":2164,"publishYear":24,"statisticByYear":2166},{"2013":78,"2014":78,"2015":78,"2017":78,"2019":78},"1998-09-01",1998,[],{"id":2171,"createTime":2172,"updateTime":2172,"relativeEntities":2173,"slug":2174,"properties":2175,"entityType":202,"verifyStatus":460,"verifyTime":2172,"verifyNote":461,"syncStatus":23,"languages":2188,"translateLanguages":24,"viewCount":25,"primaryUrl":2189,"fullTextUrl":24,"authors":2190,"publicationType":278,"publisherRelationship":2212,"citationCount":2249,"citationInfo":2250,"publishDate":2252,"publishYear":1485,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":2253,"isForceReanalyzing":441},"46fb0057-fd9f-4bc4-9991-c7210c7f95e7","2024-09-27T20:04:09.338+00:00",[],"Use-of-corticosteroids-in-neuro-oncology",{"mag":2176,"keywords":2178,"openalex":2179,"abstract":2181,"title":2182,"pm":2184,"doi":2186},{"VOID":2177},"1993029481",{},{"VOID":2180},"W1993029481",{},{"EN":2183},"Use of corticosteroids in neuro-oncology",{"VOID":2185},"7756680",{"VOID":2187},"10.1097\u002F00001813-199502000-00002",[205],"http:\u002F\u002Fjournals.lww.com\u002F00001813-199502000-00002",[2191],{"id":2192,"sortIndex":25,"researcher":24,"roles":2193,"affiliations":2194,"properties":2205},"bacc7c4b-4501-4178-be6c-47165a0df3f9",[],[2195],{"id":2196,"sortIndex":25,"affiliation":2197,"properties":24},"e87a8e85-af03-4cfc-bb3d-c631301b8eab",{"id":2198,"createTime":2199,"updateTime":2199,"relativeEntities":2200,"slug":2201,"properties":2202,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"985f5233-7cc2-40dd-bbb3-b17fdd6df5a3","2024-09-27T20:04:09.355+00:00",[],"Department-of-Neurology-de-Wever-Gregorius-Hospital-Heerlen-The-Netherlands-",{"title":2203},{"EN":2204},"Department of Neurology, de Wever & Gregorius Hospital, Heerlen, The Netherlands.",{"openalex":2206,"orcid":2208,"title":2210},{"VOID":2207},"A5028077073",{"VOID":2209},"https:\u002F\u002Forcid.org\u002F0000-0003-4356-2698",{"EN":2211},"Philip J. Koehler",{"url":24,"publisher":2213,"properties":2243},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2214,"slug":10,"properties":2215,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2221,"manageAffiliations":2222,"indexDatabases":2223,"url":165,"thumbnailPath":24,"statistic":2238,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2216,"issn":2217,"introduce":2218,"eissn":2219,"title":2220},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[2224,2231],{"id":124,"indexDatabase":2225,"url":137,"indexYears":138,"academicFieldIds":2230,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":2226,"label":2227,"description":2228,"key":134,"publicationTags":2229,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":2232,"url":161,"indexYears":24,"academicFieldIds":2237,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":2233,"label":2234,"description":2235,"key":157,"publicationTags":2236,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":2239,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":2240,"totalCitation":170,"totalCitationByYear":2241,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":2242,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":2244,"pages":2245,"issue":2247},{"VOID":1110},{"VOID":2246},"19-33",{"VOID":2248},"1",116,{"total":2249,"publishYear":24,"statisticByYear":2251},{"2012":1957,"2013":79,"2014":80,"2015":168,"2016":82,"2018":82,"2019":80,"2020":168,"2021":79,"2022":79,"2023":79,"2024":78},"1995-02-01",[],{"id":2255,"createTime":2256,"updateTime":2256,"relativeEntities":2257,"slug":2258,"properties":2259,"entityType":202,"verifyStatus":460,"verifyTime":2256,"verifyNote":461,"syncStatus":23,"languages":2272,"translateLanguages":24,"viewCount":25,"primaryUrl":2273,"fullTextUrl":24,"authors":2274,"publicationType":278,"publisherRelationship":2441,"citationCount":176,"citationInfo":2479,"publishDate":2482,"publishYear":2483,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":2484,"isForceReanalyzing":441},"7d7ee2cd-062f-4019-a364-496a8b3bafd7","2024-08-31T17:49:23.019+00:00",[],"A-dramatic-fetal-outcome-following-transplacental-transfer-of-dasatinib",{"mag":2260,"keywords":2262,"openalex":2263,"abstract":2265,"title":2266,"pm":2268,"doi":2270},{"VOID":2261},"2323497472",{},{"VOID":2264},"W2323497472",{},{"EN":2267},"A dramatic fetal outcome following transplacental transfer of dasatinib",{"VOID":2269},"22421368",{"VOID":2271},"10.1097\u002Fcad.0b013e328352a8fe",[205],"https:\u002F\u002Fjournals.lww.com\u002F00001813-201208000-00013",[2275,2307,2324,2344,2362,2384,2403,2420],{"id":2276,"sortIndex":70,"researcher":24,"roles":2277,"affiliations":2278,"properties":2300},"7b4187b6-8b85-49f1-8652-4461c0ff2f05",[],[2279,2289],{"id":2280,"sortIndex":78,"affiliation":2281,"properties":24},"ad17bc26-c7a4-4373-ad28-74f5c3d4b7ea",{"id":2282,"createTime":2283,"updateTime":2283,"relativeEntities":2284,"slug":2285,"properties":2286,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"1b687e8b-3228-4674-aeb6-d9d0ecc97519","2024-08-31T17:49:23.031+00:00",[],"PremUp-Foundation-INSERM-U767-Pharmaceutical-and-Biological-Sciences-Faculty",{"title":2287},{"EN":2288},"PremUp Foundation, INSERM U767, Pharmaceutical and Biological Sciences Faculty",{"id":2290,"sortIndex":25,"affiliation":2291,"properties":24},"148552a6-9141-4bc0-a5fe-f04225a1b85e",{"id":2292,"createTime":2293,"updateTime":2294,"relativeEntities":2295,"slug":2296,"properties":2297,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"360dd268-346c-42a4-91b4-0b59706c919d","2023-12-20T00:39:44.312+00:00","2024-08-31T17:49:23.063+00:00",[],"Gynecology-and-Obstetrics",{"title":2298},{"VI":2299},"Gynecology and Obstetrics",{"openalex":2301,"orcid":2303,"title":2305},{"VOID":2302},"A5029642865",{"VOID":2304},"https:\u002F\u002Forcid.org\u002F0000-0002-7650-6660",{"EN":2306},"Vassilis Tsatsaris",{"id":2308,"sortIndex":25,"researcher":24,"roles":2309,"affiliations":2310,"properties":2317},"b4a41a36-2519-41b9-841a-50bd477c0cd7",[],[2311],{"id":2312,"sortIndex":25,"affiliation":2313,"properties":24},"d0f951c1-f1aa-4e7f-9542-0113b6660451",{"id":2282,"createTime":2283,"updateTime":2283,"relativeEntities":2314,"slug":2285,"properties":2315,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2316},{"EN":2288},{"openalex":2318,"orcid":2320,"title":2322},{"VOID":2319},"A5039802895",{"VOID":2321},"https:\u002F\u002Forcid.org\u002F0000-0002-7814-6945",{"EN":2323},"Paul Berveiller",{"id":2325,"sortIndex":78,"researcher":24,"roles":2326,"affiliations":2327,"properties":2339},"4145e12e-5681-4f32-9b22-eb53e424ed86",[],[2328],{"id":2329,"sortIndex":25,"affiliation":2330,"properties":24},"52750fb0-7fbe-4db9-a751-b683ca4ba0a1",{"id":2331,"createTime":2332,"updateTime":2333,"relativeEntities":2334,"slug":2335,"properties":2336,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"3fe4758b-8fcf-4e13-87d4-97ad0f11ac5b","2024-01-14T11:03:34.710+00:00","2024-10-16T12:45:13.448+00:00",[],"Department-of-Haematology-",{"title":2337},{"VI":2338},"Department of Haematology,",{"openalex":2340,"title":2342},{"VOID":2341},"A5103638243",{"EN":2343},"Annalisa Andreoli",{"id":2345,"sortIndex":81,"researcher":24,"roles":2346,"affiliations":2347,"properties":2357},"5a2f2ba6-04da-4fb1-8feb-3f08d8db5232",[],[2348],{"id":2349,"sortIndex":25,"affiliation":2350,"properties":24},"d47c1e1e-5a16-4c44-91c7-e61a71856236",{"id":2351,"createTime":2352,"updateTime":2352,"relativeEntities":2353,"slug":2354,"properties":2355,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"1e1e229e-3ad6-4941-a2f2-9053586e9e3d","2024-08-31T17:49:23.075+00:00",[],"Fetopathology",{"title":2356},{"EN":2354},{"openalex":2358,"title":2360},{"VOID":2359},"A5106470297",{"EN":2361},"Anne‐Lise Delezoide",{"id":2363,"sortIndex":80,"researcher":24,"roles":2364,"affiliations":2365,"properties":2377},"6fd33715-87bf-4a27-9f9f-e57224cebacb",[],[2366],{"id":2367,"sortIndex":25,"affiliation":2368,"properties":24},"7c28f334-4983-48cd-9cf3-cb9f8a5b1ce8",{"id":2369,"createTime":2370,"updateTime":2371,"relativeEntities":2372,"slug":2373,"properties":2374,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"06e4096d-3988-4ed1-b41d-00aada4e46b0","2024-01-12T22:18:20.233+00:00","2025-06-11T19:56:50.345+00:00",[],"Medical-Oncology",{"title":2375},{"VI":2376},"Medical Oncology",{"openalex":2378,"orcid":2380,"title":2382},{"VOID":2379},"A5074959994",{"VOID":2381},"https:\u002F\u002Forcid.org\u002F0000-0002-6761-4002",{"EN":2383},"Olivier Mir",{"id":2385,"sortIndex":82,"researcher":24,"roles":2386,"affiliations":2387,"properties":2398},"42660088-371a-4c7d-8bb6-dcac6e4edb94",[],[2388],{"id":2389,"sortIndex":25,"affiliation":2390,"properties":24},"758bdf41-ea4e-4bd9-9452-87635abdbf52",{"id":2391,"createTime":2392,"updateTime":2392,"relativeEntities":2393,"slug":2394,"properties":2395,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"d95a6551-22d9-4438-acd2-8c209f09f649","2024-08-31T17:49:23.088+00:00",[],"Department-of-Pharmacology-and-Toxicology-Teaching-Hospital-Saint-Louis-AP-HP-Universit%C3%A9-Paris-7-Denis-Diderot-Paris-France",{"title":2396},{"EN":2397},"Department of Pharmacology and Toxicology, Teaching Hospital Saint Louis, AP-HP, Université Paris 7 – Denis Diderot, Paris, France",{"openalex":2399,"title":2401},{"VOID":2400},"A5050488687",{"EN":2402},"Hélène Sauvageon",{"id":2404,"sortIndex":79,"researcher":24,"roles":2405,"affiliations":2406,"properties":2413},"c21c7ef2-0790-468a-9ea0-0cbb55d79ceb",[],[2407],{"id":2408,"sortIndex":25,"affiliation":2409,"properties":24},"acc59fa2-7d5e-431b-9904-f7d80cfd328f",{"id":2292,"createTime":2293,"updateTime":2294,"relativeEntities":2410,"slug":2296,"properties":2411,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},[],{"title":2412},{"VI":2299},{"openalex":2414,"orcid":2416,"title":2418},{"VOID":2415},"A5057199231",{"VOID":2417},"https:\u002F\u002Forcid.org\u002F0000-0002-1516-3203",{"EN":2419},"O. Anselem",{"id":2421,"sortIndex":168,"researcher":24,"roles":2422,"affiliations":2423,"properties":2434},"4988fae2-85c9-4e02-ba1c-1e92616c4d90",[],[2424],{"id":2425,"sortIndex":25,"affiliation":2426,"properties":24},"4d49808d-720e-4a2f-a7b7-95e678735486",{"id":2427,"createTime":2428,"updateTime":2428,"relativeEntities":2429,"slug":2430,"properties":2431,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"6239a687-ffa9-4418-91e8-53b4f4273052","2024-08-31T17:49:23.099+00:00",[],"Biological-Hematology-Teaching-Hospital-Cochin-Saint-Vincent-de-Paul-AP-HP-Universit%C3%A9-Paris-Descartes-Sorbonne-Paris-Cit%C3%A9",{"title":2432},{"EN":2433},"Biological Hematology, Teaching Hospital Cochin – Saint Vincent de Paul, AP-HP, Université Paris Descartes, Sorbonne Paris Cité",{"openalex":2435,"orcid":2437,"title":2439},{"VOID":2436},"A5061163564",{"VOID":2438},"https:\u002F\u002Forcid.org\u002F0000-0003-0601-3948",{"EN":2440},"Nicolas Chapuis",{"url":24,"publisher":2442,"properties":2472},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2443,"slug":10,"properties":2444,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2450,"manageAffiliations":2451,"indexDatabases":2452,"url":165,"thumbnailPath":24,"statistic":2467,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2445,"issn":2446,"introduce":2447,"eissn":2448,"title":2449},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[2453,2460],{"id":124,"indexDatabase":2454,"url":137,"indexYears":138,"academicFieldIds":2459,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":2455,"label":2456,"description":2457,"key":134,"publicationTags":2458,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":2461,"url":161,"indexYears":24,"academicFieldIds":2466,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":2462,"label":2463,"description":2464,"key":157,"publicationTags":2465,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":2468,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":2469,"totalCitation":170,"totalCitationByYear":2470,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":2471,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":2473,"pages":2475,"issue":2477},{"VOID":2474},"23",{"VOID":2476},"754-757",{"VOID":2478},"7",{"total":176,"publishYear":24,"statisticByYear":2480},{"2012":80,"2013":78,"2014":80,"2015":2481,"2016":1957,"2017":320,"2018":78,"2019":80,"2020":81,"2021":78,"2024":79},12,"2012-08-01",2012,[2485,2489,2493,2497,2501,2505,2509,2513,2517,2521,2525],{"id":24,"text":2486,"url":24,"identifiers":2487},"Cortes, 2004, Natural history and staging of chronic myelogenous leukemia., Hematol Oncol Clin North Am, 18, 569, 10.1016\u002Fj.hoc.2004.03.011",{"doi":2488},"10.1016\u002Fj.hoc.2004.03.011",{"id":24,"text":2490,"url":24,"identifiers":2491},"Jabbour, 2011, Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia., Cancer, 117, 1800, 10.1002\u002Fcncr.25717",{"doi":2492},"10.1002\u002Fcncr.25717",{"id":24,"text":2494,"url":24,"identifiers":2495},"Apperley, 2009, Issues of imatinib and pregnancy outcome., J Natl Compr Canc Netw, 7, 1050, 10.6004\u002Fjnccn.2009.0069",{"doi":2496},"10.6004\u002Fjnccn.2009.0069",{"id":24,"text":2498,"url":24,"identifiers":2499},"Pye, 2008, The effects of imatinib on pregnancy outcome., Blood, 111, 5505, 10.1182\u002Fblood-2007-10-114900",{"doi":2500},"10.1182\u002Fblood-2007-10-114900",{"id":24,"text":2502,"url":24,"identifiers":2503},"Cole, 2009, Successful completion of pregnancy in a patient with chronic myeloid leukemia without active intervention: a case report and review of the literature., Clin Lymphoma Myeloma, 9, 324, 10.3816\u002FCLM.2009.n.064",{"doi":2504},"10.3816\u002FCLM.2009.n.064",{"id":24,"text":2506,"url":24,"identifiers":2507},"He, 2008, Lacteal secretion, fetal and maternal tissue distribution of dasatinib in rats., Drug Metab Dispos, 36, 2564, 10.1124\u002Fdmd.108.022764",{"doi":2508},"10.1124\u002Fdmd.108.022764",{"id":24,"text":2510,"url":24,"identifiers":2511},"Kroll, 2010, Successful management of pregnancy occurring in a patient with chronic myeloid leukemia on dasatinib., Leuk Lymphoma, 51, 1751, 10.3109\u002F10428194.2010.497982",{"doi":2512},"10.3109\u002F10428194.2010.497982",{"id":24,"text":2514,"url":24,"identifiers":2515},"Conchon, 2009, Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study., J Hematol Oncol, 2, 42, 10.1186\u002F1756-8722-2-42",{"doi":2516},"10.1186\u002F1756-8722-2-42",{"id":24,"text":2518,"url":24,"identifiers":2519},"Hochhaus, 2008, Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib., Leukemia, 22, 1200, 10.1038\u002Fleu.2008.84",{"doi":2520},"10.1038\u002Fleu.2008.84",{"id":24,"text":2522,"url":24,"identifiers":2523},"OHare, 2005, In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants., Cancer Res, 65, 4500, 10.1158\u002F0008-5472.CAN-05-0259",{"doi":2524},"10.1158\u002F0008-5472.CAN-05-0259",{"id":24,"text":2526,"url":24,"identifiers":2527},"Kantarjian, 2010, Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia., N Engl J Med, 362, 2260, 10.1056\u002FNEJMoa1002315",{"doi":2528},"10.1056\u002FNEJMoa1002315",{"id":2530,"createTime":2531,"updateTime":2531,"relativeEntities":2532,"slug":2533,"properties":2534,"entityType":202,"verifyStatus":23,"verifyTime":2531,"verifyNote":203,"syncStatus":23,"languages":2547,"translateLanguages":24,"viewCount":25,"primaryUrl":2548,"fullTextUrl":24,"authors":2549,"publicationType":278,"publisherRelationship":2619,"citationCount":2656,"citationInfo":2657,"publishDate":2661,"publishYear":2662,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":24,"openAccess":24,"references":2663,"isForceReanalyzing":441},"e93b2a71-1fe4-449a-a355-b14a5a25d1e9","2024-09-18T15:55:19.069+00:00",[],"Evaluation-of-synthetic-reconstituted-high-density-lipoproteins-as-delivery-vehicles-for-paclitaxel",{"mag":2535,"keywords":2537,"openalex":2538,"abstract":2540,"title":2541,"pm":2543,"doi":2545},{"VOID":2536},"2014360391",{},{"VOID":2539},"W2014360391",{},{"EN":2542},"Evaluation of synthetic\u002Freconstituted high-density lipoproteins as delivery vehicles for paclitaxel",{"VOID":2544},"18176115",{"VOID":2546},"10.1097\u002Fcad.0b013e3282f1da86",[205],"https:\u002F\u002Fjournals.lww.com\u002F00001813-200802000-00010",[2550,2559,2581,2590,2610],{"id":2551,"sortIndex":78,"researcher":24,"roles":2552,"affiliations":2553,"properties":2554},"487d0246-9f60-443e-958c-1e1e33e6f09b",[],[],{"openalex":2555,"title":2557},{"VOID":2556},"A5053982213",{"EN":2558},"Maya Nair",{"id":2560,"sortIndex":81,"researcher":24,"roles":2561,"affiliations":2562,"properties":2574},"b8e3c121-fdb6-4d1f-b4fb-73eda3b5717a",[],[2563],{"id":2564,"sortIndex":25,"affiliation":2565,"properties":24},"bbb4ab82-b2a0-49b1-b058-ddb9d4931d02",{"id":2566,"createTime":2567,"updateTime":2568,"relativeEntities":2569,"slug":2570,"properties":2571,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"5f8dd78b-efe0-4292-b73b-a787a07f10f3","2024-09-03T23:08:25.991+00:00","2025-02-09T10:34:14.613+00:00",[],"Univ-of-North-texas",{"title":2572},{"EN":2573},"Univ of North texas",{"openalex":2575,"orcid":2577,"title":2579},{"VOID":2576},"A5067970030",{"VOID":2578},"https:\u002F\u002Forcid.org\u002F0000-0001-9168-7802",{"EN":2580},"Andras G. Lacko",{"id":2582,"sortIndex":79,"researcher":24,"roles":2583,"affiliations":2584,"properties":2585},"bb42a560-b3f5-4dbe-ac95-9d775ae5b84a",[],[],{"openalex":2586,"title":2588},{"VOID":2587},"A5032573268",{"EN":2589},"Linda Mooberry",{"id":2591,"sortIndex":25,"researcher":24,"roles":2592,"affiliations":2593,"properties":2605},"f3ab14b9-a361-48a1-b7e4-d5538c1c80a9",[],[2594],{"id":2595,"sortIndex":25,"affiliation":2596,"properties":24},"7526c85a-d2dd-4006-b1bf-ccfe0ce7bc46",{"id":2597,"createTime":2598,"updateTime":2599,"relativeEntities":2600,"slug":2601,"properties":2602,"entityType":69,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25},"02f035f4-d940-46be-921a-334407c3b371","2024-09-18T15:55:19.084+00:00","2025-06-11T16:18:41.986+00:00",[],"Department-of-Internal-Medicine-University-of-North-Texas-Health-Science-Center-Fort-Worth-Texas-76107-USA-",{"title":2603},{"EN":2604},"Department of Internal Medicine, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA.",{"openalex":2606,"title":2608},{"VOID":2607},"A5075398812",{"EN":2609},"Walter J. McConathy",{"id":2611,"sortIndex":80,"researcher":24,"roles":2612,"affiliations":2613,"properties":2614},"099b802a-c67a-42b2-bcea-4c1fd9266798",[],[],{"openalex":2615,"title":2617},{"VOID":2616},"A5024340258",{"EN":2618},"Sulabha Paranjape",{"url":24,"publisher":2620,"properties":2650},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2621,"slug":10,"properties":2622,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"syncStatus":23,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2628,"manageAffiliations":2629,"indexDatabases":2630,"url":165,"thumbnailPath":24,"statistic":2645,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2623,"issn":2624,"introduce":2625,"eissn":2626,"title":2627},{"VOID":13},{"VOID":15},{"EN":17},{"VOID":19},{"EN":21},[],[],[2631,2638],{"id":124,"indexDatabase":2632,"url":137,"indexYears":138,"academicFieldIds":2637,"indexDatabaseRanking":144},{"id":126,"createTime":127,"updateTime":128,"relativeEntities":2633,"label":2634,"description":2635,"key":134,"publicationTags":2636,"standard":24},[],{"EN":131,"VI":131},{"EN":131,"VI":133},[136],[140,141,142,143],{"id":146,"indexDatabase":2639,"url":161,"indexYears":24,"academicFieldIds":2644,"indexDatabaseRanking":24},{"id":148,"createTime":149,"updateTime":150,"relativeEntities":2640,"label":2641,"description":2642,"key":157,"publicationTags":2643,"standard":24},[],{"EN":153,"VI":153},{"VI":155,"EN":156},[159,160],[163,164],{"impactFactor":25,"impactFactorByYear":2646,"i10Index":168,"i10IndexLast5Year":25,"totalPublication":168,"totalPublicationByYear":2647,"totalCitation":170,"totalCitationByYear":2648,"totalCitationPerPublication":178,"totalCitationPerPublicationByYear":2649,"hindexLast5Year":168,"hindex":168},{"2012":168,"2013":80,"2014":80,"2016":81,"2017":80},{"1995":78,"2004":78,"2007":78,"2011":78,"2012":78,"2015":78},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"1995":172,"2004":173,"2007":174,"2011":175,"2012":176,"2015":177},{"volume":2651,"pages":2653,"issue":2655},{"VOID":2652},"19",{"VOID":2654},"183-188",{"VOID":1927},117,{"total":2656,"publishYear":24,"statisticByYear":2658},{"2012":2659,"2013":2481,"2014":320,"2015":2660,"2016":70,"2017":168,"2018":82,"2019":320,"2020":70,"2021":320,"2022":80,"2023":81,"2024":79},11,13,"2008-02-01",2008,[2664,2668,2672,2676,2679,2682,2686,2690,2694,2698,2702,2706,2710,2714,2717,2721,2725,2729,2733,2736,2739,2743,2746,2750,2754,2758,2762,2766,2770],{"id":24,"text":2665,"url":24,"identifiers":2666},"Counsell, 1982, Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents, J Med Chem, 10, 1115, 10.1021\u002Fjm00352a001",{"doi":2667},"10.1021\u002Fjm00352a001",{"id":24,"text":2669,"url":24,"identifiers":2670},"Kader, 2002, Loading anticancer drugs into HDL as well as LDL has little effect on properties of complexes and enhances cytotoxicity to human carcinoma cells, J Control Release, 80, 29, 10.1016\u002FS0168-3659(01)00536-3",{"doi":2671},"10.1016\u002FS0168-3659(01)00536-3",{"id":24,"text":2673,"url":24,"identifiers":2674},"Firestone, 1984, Selective delivery of cytotoxic compounds to cells by the LDL pathway, J Med Chem, 27, 1037, 10.1021\u002Fjm00374a017",{"doi":2675},"10.1021\u002Fjm00374a017",{"id":24,"text":2677,"url":24,"identifiers":2678},"Lacko, 2002, High density lipoprotein complexes as delivery vehicles for anticancer drugs, Anticancer Res, 22, 2045",{},{"id":24,"text":2680,"url":24,"identifiers":2681},"Lacko, 2007, Nanotechnology in cancer therapy, 777",{},{"id":24,"text":2683,"url":24,"identifiers":2684},"Lacko, 2006, Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model, Chemotherapy, 52, 171, 10.1159\u002F000093268",{"doi":2685},"10.1159\u002F000093268",{"id":24,"text":2687,"url":24,"identifiers":2688},"Brewer, 1986, Isolation and characterization of apolipoprotein A-I, A-II and A-IV, Methods Enzymol, 128, 223, 10.1016\u002F0076-6879(86)28070-2",{"doi":2689},"10.1016\u002F0076-6879(86)28070-2",{"id":24,"text":2691,"url":24,"identifiers":2692},"Matz, 1982, Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersion, J Biol Chem, 257, 4535, 10.1016\u002FS0021-9258(18)34756-2",{"doi":2693},"10.1016\u002FS0021-9258(18)34756-2",{"id":24,"text":2695,"url":24,"identifiers":2696},"Jonas, 1986, Reconstitution of high density lipoproteins, Methods Enzymol, 128, 553, 10.1016\u002F0076-6879(86)28092-1",{"doi":2697},"10.1016\u002F0076-6879(86)28092-1",{"id":24,"text":2699,"url":24,"identifiers":2700},"Kelley, 1986, Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor, Methods Enzymol, 128, 170, 10.1016\u002F0076-6879(86)28067-2",{"doi":2701},"10.1016\u002F0076-6879(86)28067-2",{"id":24,"text":2703,"url":24,"identifiers":2704},"Terpstra, 1981, Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation, Anal Biochem, 111, 49, 10.1016\u002F0003-2697(81)90243-8",{"doi":2705},"10.1016\u002F0003-2697(81)90243-8",{"id":24,"text":2707,"url":24,"identifiers":2708},"Loney, 1997, Evaluation of gemfibrozil therapy: predictive response from lipoprotein subfraction analysis, Am J Ther, 9–10, 301, 10.1097\u002F00045391-199709000-00004",{"doi":2709},"10.1097\u002F00045391-199709000-00004",{"id":24,"text":2711,"url":24,"identifiers":2712},"Forte, 1971, Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by electron microscopy, J Clin Invest, 50, 1141, 10.1172\u002FJCI106586",{"doi":2713},"10.1172\u002FJCI106586",{"id":24,"text":2715,"url":24,"identifiers":2716},"Arnould, 1990, Comparison of two cytotoxicity assays – tetrazolium derivative reduction (MTT) and tritiated thymidine uptake – on three malignant mouse cell lines using chemotherapeutic agents and investigational drugs, Anticancer Res, 10, 145",{},{"id":24,"text":2718,"url":24,"identifiers":2719},"Urrutia-Rojas, 2004, Cardiovascular risk factors in Mexican Americans at risk for type 2 diabetes mellitus, J Adolescent Health, 34, 290, 10.1016\u002Fj.jadohealth.2003.07.005",{"doi":2720},"10.1016\u002Fj.jadohealth.2003.07.005",{"id":24,"text":2722,"url":24,"identifiers":2723},"Kieft, 1991, Rapid online determination of cholesterol among plasma lipoproteins after high performance gel filtration chromatography, J Lipid Res, 32, 859, 10.1016\u002FS0022-2275(20)42037-1",{"doi":2724},"10.1016\u002FS0022-2275(20)42037-1",{"id":24,"text":2726,"url":24,"identifiers":2727},"Ackers, 1970, Analytical gel chromatography of proteins, Adv Protein Chem, 24, 343, 10.1016\u002FS0065-3233(08)60245-4",{"doi":2728},"10.1016\u002FS0065-3233(08)60245-4",{"id":24,"text":2730,"url":24,"identifiers":2731},"Gal, 1981, Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms, Am J Obstet Gynecol, 139, 877, 10.1016\u002F0002-9378(81)90952-2",{"doi":2732},"10.1016\u002F0002-9378(81)90952-2",{"id":24,"text":2734,"url":24,"identifiers":2735},"Peterson, 1991, Lipoproteins, malignancy, and anticancer agents, Targeted Diagn Ther, 5, 175",{},{"id":24,"text":2737,"url":24,"identifiers":2738},"Lundberg, 1987, Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway, Cancer Res, 47, 4105",{},{"id":24,"text":2740,"url":24,"identifiers":2741},"Cao, 2004, Mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells, Cancer Res, 64, 1515, 10.1158\u002F0008-5472.CAN-03-0675",{"doi":2742},"10.1158\u002F0008-5472.CAN-03-0675",{"id":24,"text":2744,"url":24,"identifiers":2745},"Markel, 2004, Cancer and hypocholesterolemia, Isr J Med Sci, 30, 787",{},{"id":24,"text":2747,"url":24,"identifiers":2748},"Vitols, 1990, Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy, Proc Natl Acad Sci U S A, 87, 2598, 10.1073\u002Fpnas.87.7.2598",{"doi":2749},"10.1073\u002Fpnas.87.7.2598",{"id":24,"text":2751,"url":24,"identifiers":2752},"Goncalves, 2005, Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells, Leuk Res, 29, 955, 10.1016\u002Fj.leukres.2005.01.013",{"doi":2753},"10.1016\u002Fj.leukres.2005.01.013",{"id":24,"text":2755,"url":24,"identifiers":2756},"Zheng, 2005, Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents, Proc Natl Acad Sci U S A, 102, 17757, 10.1073\u002Fpnas.0508677102",{"doi":2757},"10.1073\u002Fpnas.0508677102",{"id":24,"text":2759,"url":24,"identifiers":2760},"Ryan, 2003, Optimized bacterial expression of human apolipoprotein A-I, Protein Expr Purif, 27, 98, 10.1016\u002FS1046-5928(02)00568-5",{"doi":2761},"10.1016\u002FS1046-5928(02)00568-5",{"id":24,"text":2763,"url":24,"identifiers":2764},"Baillie, 2002, A synthetic low density lipoprotein particle capable of supporting U937 proliferation in vitro, J Lipid Res, 43, 69, 10.1016\u002FS0022-2275(20)30188-7",{"doi":2765},"10.1016\u002FS0022-2275(20)30188-7",{"id":24,"text":2767,"url":24,"identifiers":2768},"Owens, 2001, Physicochemical properties of microemulsion analogues of low density lipoprotein containing amphiphatic apoprotein B receptor sequences, Int J Pharm, 228, 109, 10.1016\u002FS0378-5173(01)00818-3",{"doi":2769},"10.1016\u002FS0378-5173(01)00818-3",{"id":24,"text":2771,"url":24,"identifiers":2772},"Nikanjam, 2007, Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme, Int J Pharm, 328, 86, 10.1016\u002Fj.ijpharm.2006.07.046",{"doi":2773},"10.1016\u002Fj.ijpharm.2006.07.046"]